<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">96161</article-id>
<article-id pub-id-type="doi">10.7554/eLife.96161</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96161.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell Biology</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Neurons enhance blood-brain barrier function via upregulating claudin-5 and VE-cadherin expression due to GDNF secretion</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lin</surname>
<given-names>Zijin</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mu</surname>
<given-names>Ruijing</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Wenhan</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhi</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Liu</surname>
<given-names>Xiaodong</given-names>
</name>
<xref ref-type="aff" rid="a1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Hanyu</given-names>
</name>
<email>shenyhy@cpu.edu.cn</email>
<xref ref-type="aff" rid="a1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8476-2007</contrib-id>
<name>
<surname>Liu</surname>
<given-names>Li</given-names>
</name>
<email>liulee@cpu.edu.cn</email>
<xref ref-type="aff" rid="a1">a</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>a</label><institution>Department of Pharmacology, School of Pharmacy, China Pharmaceutical University</institution>, Nanjing 210009, <country>China</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Velasco</surname>
<given-names>Ivan</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Universidad Nacional Autónoma de México</institution>
</institution-wrap>
<city>Mexico City</city>
<country>Mexico</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Cooper</surname>
<given-names>Jonathan A</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Fred Hutchinson Cancer Research Center</institution>
</institution-wrap>
<city>Seattle</city>
<country>United States of America</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence. Tel./fax: +86 2583271060 Email address: <email>xdliu@cpu.edu.cn</email> (Xiaodong Liu), <email>shenyhy@cpu.edu.cn</email> (Hanyu Yang), <email>liulee@cpu.edu.cn</email> (Li Liu)</corresp>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-05-29">
<day>29</day>
<month>05</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP96161</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-02-08">
<day>08</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-02-09">
<day>09</day>
<month>02</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.07.579396"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Yang et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Yang et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-96161-v1.pdf"/>
<abstract>
<title>Abstract</title><p>Blood-brain barrier (BBB) prevents neurotoxins from entering central nervous system. We aimed to establish and characterize an <italic>in vitro</italic> triple co-culture BBB model consisting of brain endothelial cells hCMEC/D3, astrocytoma U251 cells, and neuroblastoma SH-SY5Y cells. Co-culture of SH-SY5Y and U251 cells markedly enhanced claudin-5 and VE-cadherin expression in hCMEC/D3 cells, accompanied by increased transendothelial electrical resistance and decreased permeability. Conditioned medium (CM) from SH-SY5Y cells (S-CM), U251 cells (U-CM), and co-culture of SH-SY5Y and U251 cells (US-CM) also promoted claudin-5 and VE-cadherin expression. Glial cell line-derived neurotrophic factor (GDNF) levels in S-CM and US-CM were significantly higher than CMs from hCMEC/D3 and U-CM. Both GDNF and US-CM upregulated claudin-5 and VE-cadherin expression, which were attenuated by anti-GDNF antibody and GDNF signaling inhibitors. GDNF increased claudin-5 expression via the PI3K/AKT/FOXO1 and MAPK/ERK pathways. Meanwhile, GDNF promoted VE-cadherin expression by activating PI3K/AKT/ETS1 and MAPK/ERK/ETS1 signaling. The roles of GDNF in BBB integrity were validated using brain-specific <italic>Gdnf</italic> silencing mice. The developed triple co-culture BBB model was successfully applied to predict BBB permeability. In conclusion, neurons enhance BBB integrity by upregulating claudin-5 and VE-cadherin expression through GDNF secretion and established triple co-culture BBB model may be used to predict drugs’ BBB permeability.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>Blood-Brain Barrier</kwd>
<kwd><italic>in vitro</italic> BBB model</kwd>
<kwd>Glia-derived neurotrophic factor</kwd>
<kwd>IVIVC</kwd>
<kwd>Co-culture</kwd>
<kwd>Tight junction</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>As a dynamic interface between the blood circulatory system and the central nervous system (CNS), the blood-brain barrier (BBB) maintains homeostasis and normal function of CNS by strictly regulating material exchange between the blood and brain (<xref ref-type="bibr" rid="c59">Palmiotti et al., 2014</xref>). The maintenance of BBB is mainly attributed to the expression of tight junctions (TJ) and adherent junctions (AJ) between adjacent brain endothelial cells as well as a variety of drug transporters. However, as a double-edged sword that protects CNS function, BBB also restricts the transport of some drugs from blood to brain, leading to poor CNS therapeutic effects and even CNS treatment failure (<xref ref-type="bibr" rid="c5">Banks, 2016</xref>).</p>
<p>Several <italic>in silico, in vitro, in situ,</italic> and <italic>in vivo</italic> methods have been developed to assess the permeability of drugs across BBB, but each method has its limitations (<xref ref-type="bibr" rid="c28">Hanafy et al., 2021</xref>). The <italic>in situ</italic> brain perfusion (ISBP) is considered the “gold standard” for assessing BBB permeability but there exist limits related to animal ethics. Moreover, ISBP is not suitable for human or high-throughput workflows. Thus, a suitable, accurate, and high-throughput <italic>in vitro</italic> BBB model is required to predict the permeability of drug candidates through BBB.</p>
<p>BBB is formed by neurovascular units (NVU), composed of neural (neurons, microglia, and astrocytes) and vascular components (vascular endothelial cells, pericytes, and vascular smooth muscle cells) (<xref ref-type="bibr" rid="c60">Potjewyd et al., 2018</xref>). The constant crosstalk and interactions among these cells contribute to the structural and signaling-based regulation of transcellular and paracellular transport, control of BBB permeability, and regulation of cerebral circulation (<xref ref-type="bibr" rid="c2">Arvanitis et al., 2020</xref>; <xref ref-type="bibr" rid="c53">Muoio et al., 2014</xref>; <xref ref-type="bibr" rid="c60">Potjewyd et al., 2018</xref>). Although brain microvascular endothelial cells (BMECs) are commonly utilized as an <italic>in vitro</italic> BBB model to assess drug permeability across BBB, <italic>in vitro</italic> mono-culture of BMECs tends to lose some unique characteristics without the support of other cell types. To overcome the drawbacks of mono-culture BBB models, a range of multicellular co-culture BBB models co-cultured with other NVU elements (such as astrocytes or pericytes) have been developed. Astrocytes are the most abundant glial cell type in brain (Clasadonte et al., 2017). Their terminal feet cover &gt;80% of the surface of capillaries to form interdigitating coverage without slits (<xref ref-type="bibr" rid="c50">Mathiisen et al., 2010</xref>). In addition, astrocytes also contain several proteins related to the tight binding of the basement membrane. The <italic>in vitro</italic> multicellular co-culture BBB models composed of astrocytes, pericytes, and endothelial cells are considered to mimic the vascular structure and offer paracellular tightness in BBB (<xref ref-type="bibr" rid="c34">Ito et al., 2019</xref>; <xref ref-type="bibr" rid="c54">Nakagawa et al., 2009</xref>; <xref ref-type="bibr" rid="c76">Watanabe et al., 2021</xref>).</p>
<p>Neurons also play a crucial role in the NVU and may be involved in the regulation of BBB function. The maturation of BBB in mice considerably overlaps with the establishment of neuronal activity (<xref ref-type="bibr" rid="c11">Biswas et al., 2020</xref>). A study revealed that the conditioned medium collected from primary rat neurons also attenuated cell death caused by glucose-oxygen-serum deprivation (<xref ref-type="bibr" rid="c44">Lin et al., 2016</xref>). Furthermore, the primary rat neurons were reported to affect the differentiation and formation of BMECs (<xref ref-type="bibr" rid="c63">Savettieri et al., 2000</xref>; Schiera G. et al., 2003; <xref ref-type="bibr" rid="c80">Xue et al., 2013</xref>). Recent research reported that, compared with the double co-culture of hCMEC/D3 and 1321N1 (human astrocytoma cells), the triple co-culture of hCMEC/D3, 1321N1, and human neuroblastoma SH-SY5Y cells exhibited a higher transendothelial electrical resistance (TEER) (<xref ref-type="bibr" rid="c6">Barberio et al., 2022</xref>). A similar report showed that co-cultivation of RBE4.B (rat brain capillary endothelial cells) and neurons resulted in the lower permeability of [<sup>3</sup>H] sucrose than RBE4.B cells grown alone (Schiera Gabriella. et al., 2005). All these studies indicate that neurons, as the elements of the NVU, may be tightly connected to the formation and maintenance of BBB functions.</p>
<p>The aims of the study were: 1) to establish and characterize an <italic>in vitro</italic> triple co-culture BBB model consisting of human brain endothelial cells (hCMEC/D3), human astrocytoma cells (U251), and human neuroblastoma cells (SH-SY5Y); 2) to investigate whether neurons were involved in the formation and maintenance of BBB integrity and explore their underlying mechanisms. The integrity of BBB was evaluated by quantifying the leakage of both fluorescein and FITC-Dextran 3–5 kDa (FITC-Dex); 3) to validate the <italic>in vitro</italic> results through <italic>in vivo</italic> experiments. Finally, the <italic>in vivo</italic>/<italic>in vitro</italic> correlation assay (IVIVC) was analyzed to prove that the triple co-culture BBB model could better predict the BBB penetration of CNS drugs compared with the mono-culture BBB model.</p>
</sec>
<sec id="s2">
<title>Result</title>
<sec id="s2a">
<title>Establishment and characterization of the <italic>in vitro</italic> triple co-culture BBB model</title>
<p>TEER values were measured during the co-culture (<xref rid="fig1" ref-type="fig">Figure 1C</xref>). TEER values of the four <italic>in vitro</italic> BBB models gradually increased until day 6. On day 7, the TEER values showed a decreasing trend. Thus, a 6-day co-culture was used for subsequent experiments. The highest TEER values were observed in the triple co-culture BBB model, followed by double co-culture with U251 cells and double co-culture with SH-SY5Y cells BBB models, hCMEC/D3 cells mono-culture BBB model showed the lowest TEER values. We also measured the TEER values of U251 monolayer cells, and the results showed that U251 cells themselves also contributed to the physical barrier of the model (<xref rid="fig1" ref-type="fig">Figure 1D</xref>). The apparent permeability coefficients (<italic>P<sub>app</sub></italic>) values of fluorescein and FITC-Dex were measured to characterize the integrity of the four BBB models (<xref rid="fig1" ref-type="fig">Figure 1E</xref>, 1F). Consistent with the TEER values, the triple co-culture BBB model showed the lowest permeability of fluorescein and FITC-Dex, followed by double co-culture with U251 cells and double co-culture with SH-SY5Y cells BBB models. It was noticed that the monolayer of U251 cells itself also worked as a barrier, preventing the leakage of permeability markers, which may explain why the permeability of FITC-Dex in the double co-culture model with U251 cells is lower than that in the double co-culture model with SH-SY5Y cells (<xref rid="fig1" ref-type="fig">Figure 1G</xref>). Moreover, co-culture with SH-SY5Y, U251, and U251 + SH-SY5Y cells significantly enhanced the proliferation of hCMEC/D3 cells by 5.80%, 4.61%, and 10.41%, respectively (<xref rid="fig1" ref-type="fig">Figure 1H</xref>).</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>The effects of co-culture with U251 and/or SH-SY5Y cells on the integrity of hCMEC/D3 and BBB function.</title><p>(<bold>A</bold>): Schematic diagram of the establishment process of the triple co-culture BBB model. (<bold>B</bold>): Four types of BBB models: h: hCMEC/D3 cells mono-culture model; h+S: double co-culture with SH-SY5Y cells BBB model; h+U: double co-culture with U251 cells BBB model; h+S+U: triple co-culture model. (<bold>C</bold>): The transendothelial electrical resistance (TEER) of four models, and the TEER values in day 6 were compared. Blank: the inserts without seeding cells. n=4. (<bold>D</bold>): The TEER of hCMEC/D3 and U251 cells monolayer. U: U251 cells mono-culture model. n=4. (<bold>E</bold> and <bold>F</bold>): The apparent permeability coefficient (<italic>P<sub>app</sub></italic>, × 10<sup>-6</sup> cm/s) of fluorescein (NaF) and FITC-Dextran 3–5 kDa (FITC-Dex) of four BBB models. n=4. (<bold>G</bold>): The <italic>P<sub>app</sub></italic> (× 10<sup>-6</sup> cm/s) of NaF and FITC-Dex across the blank inserts, and hCMEC/D3 or U251 mono-culture models. n=4. (<bold>H</bold>): The cell density of hCMEC/D3 cells after mono/co-culturing. n=3. (<bold>I</bold> and <bold>J</bold>): The mRNA levels of tight junction proteins, adherent junction proteins, and transporters. n=4. (<bold>K</bold> and <bold>L</bold>): The protein expression levels of claudin-5 (CLDN-5), ZO-1, occludin in hCMEC/D3 cells. n=4. (<bold>M</bold> and <bold>N</bold>): The protein expression levels of VE-cadherin (VE-Cad), <italic>β</italic>-catenin, and BCRP in hCMEC/D3 cells. n=4. (<bold>O</bold> and <bold>P</bold>): The correlations between the <italic>P<sub>app</sub></italic> (× 10<sup>-5</sup> cm/s) of NaF and claudin-5 expression (O), or VE-cadherin expression (P). (<bold>Q</bold> and <bold>R</bold>): The correlation between <italic>P<sub>app</sub></italic> (× 10<sup>-5</sup> cm/s) of FITC-Dex and claudin-5 expression (Q), or VE-cadherin expression (R). The above data are shown as the mean ± S.E.M. Statistical significance was determined using one-way ANOVA with Fisher’s LSD test or Welch’s ANOVA test. The simple linear regression analysis was used to examine the presence of a linear relationship between two variables.</p><p><bold>Figure 1—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 1—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>The paracellular barrier of BBB is associated with TJs, AJs, and transporters (<xref ref-type="bibr" rid="c1">Abbott, 2013</xref>). The mRNA levels of TJs (claudin-5, ZO-1, and occludin), AJs (VE-cadherin and <italic>β</italic>-catenin), and transporters (P-gp, BCRP, OCT-1, OCT-2, OAT-3, and OATP1A1) in hCMEC/D3 cells from the four BBB models were analyzed using qPCR (<xref rid="fig1" ref-type="fig">Figure 1I</xref> and <xref rid="fig1" ref-type="fig">1J</xref>). Compared with hCMEC/D3 cell mono-culture model, double co-culture with SH-SY5Y, double co-culture with U251, and triple co-culture BBB models showed markedly increases in claudin-5, VE-cadherin, and BCRP mRNA expression. Expression of corresponding proteins was measured using Western blot (<xref rid="fig1" ref-type="fig">Figure 1K-1N</xref>). Notably increased claudin-5 expression was detected in double co-culture with SH-SY5Y cells and triple co-culture BBB models, while VE-cadherin expression was markedly increased in double co-culture with U251 cells and triple co-culture BBB models. Expression levels of other TJ proteins (ZO-1 and occludin) and AJ protein (<italic>β</italic>-catenin) were unaltered. The expression of BCRP was slightly affected by co-cultivation without statistical differences. Significant negative correlations were found between <italic>P<sub>app</sub></italic> values of fluorescein and the expression of claudin-5 or VE-cadherin. <italic>P<sub>app</sub></italic> values of FITC-Dex were also negatively correlated to the expression levels of claudin-5 or VE-cadherin (<xref rid="fig1" ref-type="fig">Figure 1O-1R</xref>). These results indicate that the decreased permeability of fluorescein and FITC-Dex mainly results from the upregulated expression of both claudin-5 and VE-cadherin.</p>
</sec>
<sec id="s2b">
<title>Neurons and astrocytes upregulated the expression of claudin-5 and VE-cadherin by GDNF secretion</title>
<p>The hCMEC/D3 cells did not direct contact with U251 or SH-SY5Y cells in the double co-culture and triple co-culture BBB models, indicating that cell-cell interaction between U251, SH-SY5Y, and hCMEC/D3 cells relied on secreted active factors. To test this hypothesis, the effects of conditioned medium (CM) from SH-SY5Y cells (S-CM), U251 cells (U-CM), and co-culture of SH-SY5Y and U251 cells (US-CM) on the expression of claudin-5 and VE-cadherin in hCMEC/D3 cells were analyzed (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). Both S-CM, U-CM, and US-CM markedly increased the expression of claudin-5 and VE-cadherin. US-CM showed the strongest induction effects on claudin-5 and VE-cadherin.</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Neurons and astrocytes upregulated claudin-5 and VE-cadherin expression in hCMEC/D3 cells due to GDNF secretion.</title><p>(<bold>A</bold>): Effects of conditioned medium (CM) on claudin-5 and VE-cadherin expression. Con: the normal medium; S-CM: the CM from SH-SY5Y cells; U-CM: the CM from U251 cells; US-CM: the CM from SH-SY5Y cells co-culture with U251 cells. (<bold>B</bold>): The mRNA expression levels of neurotrophic factors in hCMEC/D3, U251, and SH-SY5Y cells. (<bold>C</bold>): Concentrations of GDNF, bFGF, IGF-1, and TGF-<italic>β</italic> in the CMs. H-CM: the CM from hCMEC/D3 cells. (<bold>D</bold>-<bold>G</bold>): Effects of GDNF (D), IGF-1 (E), bFGF (F), and TGF-<italic>β</italic> (G) on the expression of claudin-5 and VE-cadherin. The dosages have been marked in the figure. (<bold>H</bold> and <bold>I</bold>): Effects of anti-GDNF antibody on the upregulation of claudin-5 and VE-cadherin expression induced by US-CM (H) or 200 pg/mL GDNF (I). (<bold>J</bold>): Effects of 200 pg/mL GDNF and US-CM on claudin-5 and VE-cadherin expression in primary rat brain microvascular endothelial cells. (<bold>K</bold> and <bold>L</bold>): Effects of 3 μM RET tyrosine kinase inhibitor SSP-86 (SPP), and 5 μM Src family kinases inhibitor PP2 on the upregulation of claudin-5 and VE-cadherin induced by 200 pg/mL GDNF (K) and US-CM (L). (<bold>M</bold> and <bold>N</bold>): Effects of SPP on the TEER (M), the permeability of NaF, and FITC-Dex (N) of the hCMEC/D3 mono-culture BBB model treating 200 pg/mL GDNF. The TEER values of day 6 were compared. (<bold>O</bold> and <bold>P</bold>): Effects of PP2 on the TEER (O), the permeability of NaF, and FITC-Dex (P) of the hCMEC/D3 mono-culture BBB model treating 200 pg/mL GDNF. The TEER values of day 6 were compared. (<bold>Q</bold> and <bold>R</bold>): Effects of SPP on the TEER (Q), the permeability of NaF, and FITC-Dex (R) of the triple co-culture BBB model. The TEER values of day 6 were compared. (<bold>S</bold> and <bold>T</bold>): Effects of PP2 on the TEER (S), the permeability of NaF, and FITC-Dex (T) of the triple co-culture BBB model. The TEER values of day 6 were compared. The above data are shown as the mean ± S.E.M.; n=4. Statistical significance was determined using one-way ANOVA with Fisher’s LSD test or Welch’s ANOVA test.</p><p><bold>Figure 2—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 2—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>To investigate which cytokines were involved in the promotion of hCMEC/D3 cell integrity by U251 and SH-SY5Y cells, the mRNA expression levels of various cytokines in these three types of cells were compared. The results showed that U251 or SH-SY5Y cells exhibited significantly higher expression levels of GDNF, nerve growth factor (NGF), insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and transforming growth factor-<italic>β</italic> (TGF-<italic>β</italic>) compared to hCMEC/D3 cells (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). Furthermore, the mRNA expression of GDNF, IGF-1, TGF-<italic>β</italic>, and bFGF in SH-SY5Y cells was higher than those in U251 cells In these cytokines, GDNF (Dong et al., 2018; <xref ref-type="bibr" rid="c33">Igarashi et al., 1999</xref>; <xref ref-type="bibr" rid="c67">Shimizu et al., 2012</xref>), bFGF (<xref ref-type="bibr" rid="c66">Shimizu et al., 2011</xref>; <xref ref-type="bibr" rid="c74">Wang et al., 2016</xref>), IGF-1 (Ko et al., 2009; <xref ref-type="bibr" rid="c56">Nowrangi et al., 2019</xref>), and TGF-<italic>β</italic> (<xref ref-type="bibr" rid="c27">Fu et al., 2021</xref>) have been reported to promote BBB integrity. Thus, the concentrations of GDNF, bFGF, IGF-1, and TGF-<italic>β</italic> in the CMs were measured (<xref rid="fig2" ref-type="fig">Figure 2C</xref>). The results showed that levels of GDNF, bFGF, and IGF-1 in S-CM and US-CM were significantly higher than CMs from hCMEC/D3 cells (H-CM) and U-CM, but levels of TGF-<italic>β</italic> in S-CM and U-CM were lower than those in H-CM. Interestingly, the level of IGF-1 in US-CM was remarkably lower than that in S-CM, indicating that U251 cells suppressed IGF-1 secretion from SH-SY5Y. The effects of GDNF, bFGF, IGF-1, and TGF-<italic>β</italic> on the expression of claudin-5 and VE-cadherin were investigated (<xref rid="fig2" ref-type="fig">Figure 2D-2G</xref>). Among the four tested neurotrophic factors, only GDNF induced the expression of claudin-5 and VE-cadherin in a concentration-dependent manner (<xref rid="fig2" ref-type="fig">Figure 2D</xref>). In contrast, a high level (5 ng/mL) of TGF-<italic>β</italic> slightly downregulated claudin-5 and VE-cadherin expression (<xref rid="fig2" ref-type="fig">Figure 2G</xref>). These results demonstrate that upregulation of claudin-5 and VE-cadherin expression by US-CM are attributed to secreted GDNF.</p>
<p>To provide additional verification of the deduction, anti-GDNF antibody was used to neutralize exogenous and endogenous GDNF in culture medium. Consistent with our expectation, the anti-GDNF antibody concentration-dependent reversed the US-CM-induced claudin-5 and VE-cadherin expression (<xref rid="fig2" ref-type="fig">Figure 2H</xref>). Furthermore, GDNF-induced upregulation of claudin-5 and VE-cadherin expression was also reversed by the anti-GDNF antibody (<xref rid="fig2" ref-type="fig">Figure 2I</xref>). The induction effects of US-CM and GDNF on the claudin-5 and VE-cadherin expression in hCMEC/D3 cells were also confirmed in primary rat brain microvascular endothelial cells (<xref rid="fig2" ref-type="fig">Figure 2J</xref>)</p>
<p>GDNF forms a heterohexameric complex with two GFR<italic>α</italic>1 molecules and two RET receptors to activate the GDNF-GFR<italic>α</italic>1-RET signaling (<xref ref-type="bibr" rid="c25">Fielder et al., 2018</xref>). The RET receptor tyrosine kinase inhibitor SPP-86 (<xref ref-type="bibr" rid="c8">Bhallamudi et al., 2021</xref>) and Src-type kinase inhibitor PP2 (<xref ref-type="bibr" rid="c52">Morita et al., 2006</xref>) were used to further investigate whether GDNF upregulated the expression of claudin-5 and VE-cadherin in hCMEC/D3 cells by activating the GDNF-GFR<italic>α</italic>1-RET signaling pathway. Both SPP-86 and PP2 markedly attenuated claudin-5 and VE-cadherin expression induced by GDNF (<xref rid="fig2" ref-type="fig">Figure 2K</xref>) and US-CM (<xref rid="fig2" ref-type="fig">Figure 2L</xref>).</p>
<p>The contributions of GDNF-induced claudin-5 and VE-cadherin expression to TEER and permeability were investigated using hCMEC/D3 cells mono-culture BBB model. GDNF significantly increased TEER values (<xref rid="fig2" ref-type="fig">Figure 2M</xref>, 2O) and decreased the permeability of fluorescein and FITC-Dex (<xref rid="fig2" ref-type="fig">Figure 2N</xref>, 2P), which were almost abolished by SPP-86 or PP2. Furthermore, treatment with SPP-86 or PP2 completely reversed the increased TEER values (<xref rid="fig2" ref-type="fig">Figure 2Q</xref>, 2S) and decreased permeability of fluorescein and FITC-Dex (Figure. 2R, 2T) in the triple co-culture BBB model. These results indicate that neurons but also astrocytes upregulate claudin-5 and VE-cadherin expression in hCMEC/D3 cells by secreting GDNF. Subsequently, GDNF induces claudin-5 and VE-cadherin expression by activating GDNF-GFR<italic>α</italic>1-RET signaling.</p>
</sec>
<sec id="s2c">
<title>GDNF induced claudin-5 and VE-cadherin expression of hCMEC/D3 by activating the PI3K/AKT and MAPK/ERK pathways</title>
<p>GDNF exerts its biological activities by activating several signaling pathways, including the phosphatidylinositol-3-kinase (PI3K)/ protein kinase B (AKT), mitogen-activated protein kinase (MAPK)/ extracellular regulated kinase (ERK), MAPK/ c-Jun N-terminal kinase (JNK), and MAPK/ p38 pathways (<xref ref-type="bibr" rid="c25">Fielder et al., 2018</xref>). The effects of the PI3K/AKT, MAPK/ERK, MAPK/JNK, and MAPK/p38 pathway inhibitors LY294002 (<xref rid="fig3" ref-type="fig">Figure 3A</xref>), U0126 (<xref rid="fig3" ref-type="fig">Figure 3B</xref>), SP600125 (<xref rid="fig3" ref-type="fig">Figure 3C</xref>), and SB203580 (<xref rid="fig3" ref-type="fig">Figure 3D</xref>), respectively, on GDNF-induced claudin-5 and VE-cadherin expression in hCMEC/D3 cells were investigated. GDNF increased claudin-5 and VE-cadherin expression, accompanied by the phosphorylation of AKT (p-AKT) and ERK (p-ERK). However, it did not stimulate the phosphorylation of JNK and p38. SPP-86, LY29002, and U0126 significantly suppressed GDNF-induced claudin-5 and VE-cadherin expression, while SP600125 and SB203580 had almost no effect on GDNF-induced claudin-5 and VE-cadherin expression. GDNF-induced phosphorylation of AKT and ERK was also markedly attenuated by the anti-GDNF antibody (<xref rid="fig3" ref-type="fig">Figure 3E</xref>). Similarly, US-CM remarkably upregulated the expression of claudin-5, VE-cadherin, p-AKT, and p-ERK, which were also markedly reversed by SPP-86, LY29002, U0126, or anti-GDNF antibody (<xref rid="fig3" ref-type="fig">Figure 3F-3J</xref>). These findings indicate that GDNF induces the expression of claudin-5 and VE-cadherin in hCMEC/D3 cells by activating both the PI3K/AKT and MAPK/ERK pathways.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>GDNF induced claudin-5 and VE-cadherin expression in hCMEC/D3 cells by activating the PI3K/AKT and MAPK/ERK signaling.</title><p>(<bold>A</bold>): Effects of 3 μM LY294002 (LY) on the levels of claudin-5, VE-cadherin, and p-AKT/AKT in hCMEC/D3 cells stimulated by 200 pg/mL GDNF. (<bold>B</bold>): Effects of 2 μM U0126 (U0) on the levels of claudin-5, VE-cadherin, and p-ERK/ERK in hCMEC/D3 cells stimulated by 200 pg/mL GDNF. (<bold>C</bold>): Effects of 5 μM SP600125 (SP) on the levels of claudin-5, VE-cadherin, and p-JNK/JNK in hCMEC/D3 cells stimulated by 200 pg/mL GDNF. (<bold>D</bold>): Effects of 2 μM SB203580 (SB) on the levels of claudin-5, VE-cadherin, and p-p38/p38 in hCMEC/D3 cells stimulated by 200 pg/mL GDNF. (<bold>E</bold>): Effects of anti-GDNF antibody on the GDNF-induced p-AKT/AKT and p-ERK/ERK ratios. (<bold>F</bold>): Effects of 3 μM LY on the levels of claudin-5, VE-cadherin, and p-AKT/AKT in hCMEC/D3 cells stimulated by US-CM. (<bold>G</bold>): Effects of 2 μM U0 on the levels of claudin-5, VE-cadherin, and p-ERK/ERK in hCMEC/D3 cells stimulated by US-CM. (<bold>H</bold>): Effects of 5 μM SP on the levels of claudin-5, VE-cadherin, and p-JNK/JNK in hCMEC/D3 cells stimulated by US-CM. (<bold>I</bold>): Effects of 2 μM SB on the levels of claudin-5, VE-cadherin, and p-p38/p38 in hCMEC/D3 cells stimulated by 2 US-CM. (<bold>J</bold>): Effects of anti-GDNF antibody on the US-CM-induced p-AKT/AKT and p-ERK/ERK ratios. The above data are shown as the mean ± S.E.M.; n=4. Statistical significance was determined using one-way ANOVA with Fisher’s LSD test or Welch’s ANOVA test.</p><p><bold>Figure 3—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 3—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2d">
<title>GDNF upregulated the claudin-5 expression in hCMEC/D3 cells by activating the PI3K/AKT/FOXO1 pathway</title>
<p>Claudin-5 is negatively regulated by the transcriptional repressor forkhead box O1 (FOXO1) (<xref ref-type="bibr" rid="c7">Beard et al., 2020</xref>). FOXO1 is also an important target of PI3K/AKT signaling. FOXO1 phosphorylation results in FOXO1 accumulation in the cytoplasm (<xref ref-type="bibr" rid="c82">Zhang et al., 2011</xref>) and lowers its level in the nucleus. Here, we investigated whether GDNF-induced claudin-5 expression is involved in FOXO1 nuclear exclusion. As shown in <xref rid="fig4" ref-type="fig">Figure 4A</xref>, both GDNF and US-CM significantly enhanced FOXO1 phosphorylation (p-FOXO1). Similarly, GDNF and US-CM increased the levels of phosphorylated and unphosphorylated FOXO1 in the cytoplasm and decreased the levels of nuclear FOXO1 (<xref rid="fig4" ref-type="fig">Figure 4B</xref>). Whether FOXO1 was involved in the GDNF-induced regulation of claudin-5 and VE-cadherin expression was investigated in hCMEC/D3 cells transfected with <italic>FOXO1</italic> siRNA. Silencing <italic>FOXO1</italic> significantly decreased FOXO1 levels in both whole-cell lysates and nucleus of hCMEC/D3 cells (<xref rid="fig4" ref-type="fig">Figure 4C</xref>), demonstrating <italic>FOXO1</italic> silencing efficacy. Consistent with our expectation, silencing <italic>FOXO1</italic> upregulated the expression of claudin-5 rather than VE-cadherin expression (<xref rid="fig4" ref-type="fig">Figure 4D</xref>). In contrast, high levels of FOXO1 were observed in both whole-cell lysates and nucleus of hCMEC/D3 cells that were transfected with plasmids containing <italic>FOXO1</italic>. Meanwhile, FOXO1 overexpression resulted in a decrease in both basal and GDNF-induced claudin-5 expression (<xref rid="fig4" ref-type="fig">Figure 4E</xref>), consistent with the known role of FOXO1 on claudin-5 expression.</p>
<p>Several reports have demonstrated that nuclear localization of FOXO1 is modulated by multiple pathways, including the PI3K/AKT (<xref ref-type="bibr" rid="c71">Tang et al., 1999</xref>) and MAPK/ERK (<xref ref-type="bibr" rid="c3">Asada et al., 2007</xref>) pathways. The effects of LY294002 and U0126 on GDNF-induced FOXO1 phosphorylation were measured in hCMEC/D3 cells. LY294002, but not U0126, significantly reversed the GDNF-induced alterations in total p-FOXO1, cytoplasmic p-FOXO1, cytoplasmic FOXO1, and nuclear FOXO1 (<xref rid="fig4" ref-type="fig">Figure 4F</xref>). Furthermore, LY294002 reversed the upregulation of claudin-5 expression induced by <italic>FOXO1</italic> siRNA and GDNF (<xref rid="fig4" ref-type="fig">Figure 4G</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>GDNF induced the claudin-5 expression in hCMEC/D3 cells by activating the PI3K/AKT/FOXO1 pathway.</title><p>(<bold>A</bold> and <bold>B</bold>): Effects of US-CM and GDNF on the phosphorylated FOXO1 (p-FOXO1)/FOXO1 ratio, total FOXO1 expression (A), cytoplasmic p-FOXO1, cytoplasmic FOXO1, and nuclear FOXO1 expression (B). (<bold>C</bold> and <bold>D</bold>): The expression levels of total and nuclear FOXO1 (C), claudin-5, and VE-cadherin (D) in hCMEC/D3 cells transfected with <italic>FOXO1</italic> siRNA (siFOXO1). NC: negative control. (<bold>E</bold>): Effects of <italic>FOXO1</italic> overexpression (FOXO1-OE) and GDNF on the expression levels of claudin-5, total FOXO1, and nuclear FOXO1. FOXO1-NC: negative control plasmids. (<bold>F</bold>): Effects of LY and U0 on GDNF-induced alterations of total p-FOXO1/FOXO1 ratio, cytoplasmic p-FOXO1, cytoplasmic FOXO1, and nuclear FOXO1 expression. (<bold>G</bold>): Effects of LY on the claudin-5 expression upregulated by siFOXO1. The above data are shown as the mean ± S.E.M.; n=4. Statistical significance was determined using one-way ANOVA with Fisher’s LSD test.</p><p><bold>Figure 4—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 4—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2e">
<title>GDNF upregulated VE-cadherin expression in hCMEC/D3 cells by activating the PI3K/AKT/ETS1 and MAPK/ERK/ETS1 signaling pathways</title>
<p>E26 oncogene homolog 1 (ETS1) is a transcription factor that binds to the ETS-binding site located in the proximal region of the VE-cadherin promoter, hence regulating the expression of VE-cadherin (<xref ref-type="bibr" rid="c38">Lelièvre et al., 2000</xref>; <xref ref-type="bibr" rid="c49">Luo et al., 2022</xref>). Activation of the PI3K/AKT (<xref ref-type="bibr" rid="c31">He et al., 2023</xref>; <xref ref-type="bibr" rid="c32">Hui et al., 2018</xref>) and MAPK/ERK (<xref ref-type="bibr" rid="c75">Watanabe et al., 2004</xref>) pathways was reported to upregulate the expression of ETS1. The previous results showed that GDNF induced VE-cadherin and claudin-5 expression in hCMEC/D3 cells by activating the PI3K/AKT and MAPK/ERK pathways. Therefore, we hypothesized that GDNF modulated ETS1 levels to promote VE-Cadherin and claudin-5 expression through PI3K/AKT and MAPK/ERK signaling pathways. Both US-CM and GDNF significantly increased total (<xref rid="fig5" ref-type="fig">Figure 5A</xref>) and nuclear ETS1 expression (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). LY294002 and U0126 markedly attenuated GDNF-induced total (<xref rid="fig5" ref-type="fig">Figure 5C</xref>) and nuclear ETS1 expression (<xref rid="fig5" ref-type="fig">Figure 5D</xref>). To further confirm the involvement of the PI3K/AKT/ETS1 and MAPK/ERK/ETS1 pathways in GDNF-induced VE-cadherin expression, ETS1 in hCMEC/D3 cells was knocked down using <italic>ETS1</italic> siRNA<italic>. ETS1</italic> silencing saliently declined the expression levels of total (<xref rid="fig5" ref-type="fig">Figure 5E</xref>) and nuclear (<xref rid="fig5" ref-type="fig">Figure 5F</xref>) ETS1 in hCMEC/D3 cells, demonstrating silencing efficacy. In <italic>ETS1</italic> silencing hCMEC/D3 cells, GDNF no longer induced the expression of total (<xref rid="fig5" ref-type="fig">Figure 5E</xref>) and nuclear (<xref rid="fig5" ref-type="fig">Figure 5F</xref>) ETS1. Moreover, <italic>ETS1</italic> silencing substantially downregulated VE-cadherin expression and attenuated GDNF-induced VE-cadherin expression (<xref rid="fig5" ref-type="fig">Figure 5G</xref> and 5H), while having minimal impact on both basal and GDNF-induced claudin-5 expression (<xref rid="fig5" ref-type="fig">Figure 5G</xref> and <xref rid="fig5" ref-type="fig">5I</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>GDNF induced VE-cadherin expression in hCMEC/D3 cells by activating the PI3K/AKT/ETS1 and MAPK/ERK/ETS1 pathways.</title><p>(<bold>A</bold> and <bold>B</bold>): Effects of US-CM and GDNF on total (A) and nuclear (B) ETS1 expression. (<bold>C</bold> and <bold>D</bold>): Effects of LY and U0 on 200 pg/mL GDNF-induced total (C) and nuclear (D) ETS1 expression. (<bold>E</bold> and <bold>F</bold>): Expression levels of total (E) and the nuclear ETS1 (F) in hCMEC/D3 cells after knocking down <italic>ETS1</italic> with siRNA (siETS1). (<bold>G</bold>-<bold>I</bold>): Effects of GDNF and siETS1 on the expression of VE-cadherin and claudin-5. The above data are shown as the mean ± S.E.M.; n=4. Statistical significance was determined using one-way ANOVA with Fisher’s LSD test.</p><p><bold>Figure 5—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 5—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2f">
<title>Brain GDNF deficiency increased BBB permeability partly due to the impairment of claudin-5 and VE-cadherin expression</title>
<p>To further demonstrate the positive effects of GDNF on BBB maintenance, GDNF in mice brains was knocked down via intracerebroventricular injection of AAV-PHP.eB packaged with <italic>Gdnf</italic> short hairpin RNA (shRNA) (<xref rid="fig6" ref-type="fig">Figure 6A</xref>). Knockdown efficiency was confirmed through Western blotting (<xref rid="fig6" ref-type="fig">Figure 6B</xref>). Consistent with <italic>in vitro</italic> results, GDNF knockdown greatly downregulated the expression of claudin-5 and VE-cadherin in the brains of mice (<xref rid="fig6" ref-type="fig">Figure 6B</xref>). The integrity of BBB was assessed by examining the brain distributions of fluorescein and FITC-Dex. The results showed that specifically knocking down brain GDNF little affected plasma levels of fluorescein (<xref rid="fig6" ref-type="fig">Figure 6C</xref>) and FITC-Dex (<xref rid="fig6" ref-type="fig">Figure 6F</xref>), but significantly elevated the concentrations of fluorescein (<xref rid="fig6" ref-type="fig">Figure 6D</xref>) and FITC-Dex (<xref rid="fig6" ref-type="fig">Figure 6G</xref>) in the brains, leading to notable increases in the brain-to-plasma concentration ratios of two probes (<xref rid="fig6" ref-type="fig">Figure 6E</xref> and 6H). These alterations were consistent with the decline in claudin-5 and VE-cadherin expression. In addition, significant reductions in the levels of p-AKT (<xref rid="fig6" ref-type="fig">Figure 6I</xref>), p-ERK (<xref rid="fig6" ref-type="fig">Figure 6J</xref>), p-FOXO1 (<xref rid="fig6" ref-type="fig">Figure 6K</xref>), and ETS1 expression (<xref rid="fig6" ref-type="fig">Figure 6L</xref>) were observed in the brains of <italic>Gdnf</italic> knockdown mice.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>The deficiency of brain GDNF in mice increased the permeability of BBB and reduced claudin-5 and VE-cadherin expression in mice brains.</title><p>(<bold>A</bold>): Experimental configuration of AAV-GFP (shNC) or AAV-sh<italic>Gdnf</italic> (sh<italic>Gdnf</italic>) intracerebroventricular injection. (<bold>B</bold>): Effects of brain-specific <italic>Gdnf</italic> silencing on the expression levels of GDNF, claudin-5, and VE-cadherin in the brains. (<bold>C</bold>-<bold>E</bold>): Effects of brain-specific <italic>Gdnf</italic> silencing on NaF levels in plasma (C), brain (D), and the ratio of brain to plasma (E). (<bold>F</bold>-<bold>H</bold>): Effects of brain-specific <italic>Gdnf</italic> silencing on FITC-Dex levels in plasma (F), brain (G), and the ratio of brain to plasma (H). (<bold>I</bold>-<bold>K</bold>): The expression ratios of p-AKT/AKT (I), p-ERK/ERK (J), and p-FOXO1/FOXO1 (K) in the brains of <italic>Gdnf</italic> silencing mice. (<bold>L</bold>): The expression level of ETS1 in the brains of <italic>Gdnf</italic> silencing mice. The above data are shown as the mean ± S.E.M.; n=6. Statistical significance was determined using the unpaired t-test or unpaired t-test with Welch’s correction.</p><p><bold>Figure 6—source data1 (Raw and annotated data files for western blot)</bold></p><p><bold>Figure 6—source data2 (Summary of original data and analysis)</bold></p></caption>
<graphic xlink:href="579396v1_fig6.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s2g">
<title>The triple co-culture BBB model better predicted the permeabilities of drugs across BBB</title>
<p>This study demonstrated that the developed triple co-culture BBB model displays better BBB characteristics compared with the hCMEC/D3 mono-culture BBB model. In this study, 18 drugs were utilized to further investigate the superiority of the developed triple co-culture BBB model over the hCMEC/D3 mono-culture BBB model. The <italic>P<sub>app</sub></italic>of the 18 drugs from the apical to the basolateral side based on the hCMEC/D3 mono-culture (<italic>P<sub>app, Mono</sub></italic>) and triple co-culture (<italic>P<sub>app, Triple</sub></italic>) BBB models are measured and listed in <xref rid="tbl5" ref-type="table">Table 5</xref>. The results showed that <italic>P<sub>app, Triple</sub></italic>values of all tested drugs were lower than the <italic>P<sub>app, Mono</sub></italic> values. Significant differences were observed in 14 out of 18 drugs. The predicted permeability coefficient-surface area product values (<italic>PS</italic>) of the tested drugs were respectively calculated based on their <italic>P<sub>app, Mono</sub></italic> values (<italic>PS <sub>Pre, Mono</sub></italic>), and <italic>P<sub>app, Triple</sub></italic> values (<italic>PS <sub>Pre, Triple</sub></italic>). The predicted <italic>PS</italic> values were further compared to their corresponding observations (<italic>PS <sub>obs</sub></italic>). The results showed that the predictive accuracy of <italic>PS <sub>Pre, Triple</sub></italic> was superior to <italic>PS <sub>Pre, Mono</sub></italic>. Except for verapamil, amitriptyline, fluoxetine, and clozapine, the predicted <italic>PS <sub>Pre, Triple</sub></italic>values of the other 14 drugs in the triple co-culture BBB models were within the 0.5–2 folds of <italic>PS <sub>obs</sub></italic>(<xref rid="fig7" ref-type="fig">Figure 7B</xref>). However, in the hCMEC/D3 mono-culture BBB model, only 7 predicted <italic>PS <sub>Pre, Mono</sub></italic> values were within the 0.5–2 folds range of their observations (<xref rid="fig7" ref-type="fig">Figure 7A</xref>).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title><italic>In vitro</italic>/<italic>in vivo</italic> correlation (IVIVC) assay of BBB permeability.</title><p>(<bold>A</bold>): The comparison of the estimated permeability coefficient-surface area product (<italic>PS <sub>Mono</sub></italic>) recalculated from <italic>P<sub>app, Mono</sub></italic> with the observed <italic>in vivo PS</italic> values (<italic>PS <sub>Obs</sub></italic>). (<bold>B</bold>): The comparison of the estimated permeability coefficient-surface area product (<italic>PS <sub>Triple</sub></italic>) recalculated from <italic>P<sub>app, Triple</sub></italic> with the observed <italic>in vivo PS</italic> values (<italic>PS <sub>Obs</sub></italic>). The solid line represents a perfect prediction, and the dashed lines represent the 0.5-2 folds of their observations. The <italic>PS <sub>Obs</sub></italic> values were determined by <italic>in situ</italic> brain perfusion in rodents, which were collected from the literature.</p></caption>
<graphic xlink:href="579396v1_fig7.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s3">
<title>Discussion</title>
<p>The main findings of the study were to successfully develop an <italic>in vitro</italic> triple co-culture BBB model consisting of hCMEC/D3, U251, and SH-SY5Y cells and to confirm the involvement of neurons in BBB maintenance as well as the possible mechanisms. Co-culture with U251 and/or SH-SY5Y cells markedly promoted the TEER of hCMEC/D3 cells and reduced the leakage of fluorescein and FITC-Dex due to the upregulation of claudin-5 and VE-cadherin expression.</p>
<p>The roles of claudin-5 and VE-cadherin in the maintenance of BBB function have been demonstrated (<xref ref-type="bibr" rid="c17">Dejana et al., 2008</xref>; <xref ref-type="bibr" rid="c29">Hashimoto et al., 2023</xref>; Li W. et al., 2018; <xref ref-type="bibr" rid="c57">Ohtsuki et al., 2007</xref>). It was reported that <italic>Cld-5</italic>–deficient mice exhibited BBB impairment, allowing the transport of small molecules (&lt;800 D) across BBB (<xref ref-type="bibr" rid="c55">Nitta et al., 2003</xref>). In contrast, claudin-5 overexpression significantly restricted the permeability of inulin across the conditionally immortalized rat brain capillary endothelial cell monolayer (<xref ref-type="bibr" rid="c57">Ohtsuki et al., 2007</xref>). Moreover, the claudin-5 expression in hCMEC/D3 is much lower than in human brain microvessels (<xref ref-type="bibr" rid="c22">Eigenmann et al., 2013</xref>; <xref ref-type="bibr" rid="c58">Ohtsuki et al., 2013</xref>; <xref ref-type="bibr" rid="c78">Weksler et al., 2013</xref>), which may cause the low TEER values. VE-cadherin, a major member of the cadherin family in endothelial cells, is also required for BBB integrity (<xref ref-type="bibr" rid="c17">Dejana et al., 2008</xref>; Li W. et al., 2018). The absence of VE-cadherin resulted in faulty cell-to-cell junctions and disrupted distribution of ZO-1 (<xref ref-type="bibr" rid="c62">Sauteur et al., 2017</xref>; <xref ref-type="bibr" rid="c73">Tunggal et al., 2005</xref>). Strongly negative correlations between <italic>P<sub>app</sub></italic> values of fluorescein or FITC-Dex and the expression of claudin-5 or VE-cadherin further demonstrated the importance of claudin-5 and VE-cadherin in BBB integrity.</p>
<p>Neurons and astrocytes, as important components of the NVU, may be involved in the formation and maintenance of BBB function. Several reports showed that co-culture with astrocytes CC-2565 or SC-1810 enhanced the TEER of hCMEC/D3 cells (<xref ref-type="bibr" rid="c30">Hatherell et al., 2011</xref>), whereas co-culture of RBE4.B cells with primary rat neurons and astrocytes showed a lower permeability of [<sup>3</sup>H] sucrose than mono-culture of RBE4.B cells (Schiera Gabriella. et al., 2005). Similarly, co-cultured with hCMEC/D3 cells and 1321N1 (astrocytes) or 1321N1+SH-SY5Y cells possess higher TEER values and lower permeability to Lucifer yellow than hCMEC/D3 alone. Compared with double co-culture of hCMEC/D3 and 321N1 cells, the triple co-culture of hCMEC/D3, 1321N1, and SH-SY5Y cells showed higher TEER values (<xref ref-type="bibr" rid="c6">Barberio et al., 2022</xref>). Our study also demonstrated that co-culture with U251 and/or SH-SY5Y cells significantly lowered BBB permeability and upregulated VE-cadherin or claudin-5 expression in hCMEC/D3 cells.</p>
<p>Next, we focused on the molecular mechanisms by which neurons and possibly astrocytes upregulated the expression of VE-cadherin and claudin-5 in BMECs. Co-culture with SH-SY5Y cells significantly upregulated claudin-5 and VE-cadherin expression in hCMEC/D3 cells. In the double co-culture with SH-SY5Y cells or triple co-culture BBB models, hCMEC/D3 cells were not in direct contact with SH-SY5Y cells, indicating that the interaction between SH-SY5Y and hCMEC/D3 cells depended on the release of some active compounds. It was consistent with the above deduction that the S-CM also markedly induced claudin-5 and VE-cadherin expression. Different from S-CM, U-CM mainly upregulated the expression of VE-cadherin and just had a slight impact on claudin-5 expression. In general, neurons but also astrocytes secrete some neurotrophic factors (<xref ref-type="bibr" rid="c48">Lonka-Nevalaita et al., 2010</xref>; <xref ref-type="bibr" rid="c69">Sweeney et al., 2019</xref>) that could contribute to the maintenance of structural stability of BBB. High levels of bFGF, GDNF, IGF-1, and TGF-<italic>β</italic> were detected in U-CM, S-CM, and US-CM. Further research showed that only GDNF induced VE-cadherin and claudin-5 expression in hCMEC/D3 cells in a concentration-dependent manner, and the anti-GDNF antibody attenuated claudin-5 and VE-cadherin expression induced by US-CM or GDNF. These results indicated that neurons upregulated claudin-5 and VE-cadherin expression through GDNF secretion. Levels of GDNF in S-CM were higher than those in U-CM, which seemed to partly explain why S-CM has a stronger promoting effect on claudin-5 than U-CM. The roles of GDNF in BBB maintenance and the regulation of claudin-5 and VE-cadherin expression were further confirmed using brain-specific <italic>Gdnf</italic> knockdown C57BL/6J mice. Consistent with our <italic>in vitro</italic> results, brain-specific <italic>Gdnf</italic> silencing greatly increased BBB penetration of fluorescein and FITC-Dex, accompanied by the downregulation of claudin-5 and VE-cadherin expression.</p>
<p>Generally, GDNF activates several signal transduction pathways, such as the PI3K/AKT and MAPK signaling pathways (<xref ref-type="bibr" rid="c25">Fielder et al., 2018</xref>) by forming a heterohexameric complex with two GFR<italic>α</italic> molecules and RET receptors. It was also reported that GDNF improved BBB barrier function due to the activation of MAPK/ERK1 (Dong et al., 2018) and PI3K/AKT (Liu D. et al., 2022) signaling. Consistent with previous reports, we found that signaling inhibitors SPP-86, PP2, LY294002, and U0126 markedly attenuated US-CM– and GDNF-induced claudin-5 and VE-cadherin expression in hCMEC/D3 cells, inferring that GDNF promoted claudin-5 and VE-cadherin expression via activating both the PI3K/AKT and MAPK/ERK pathways.</p>
<p>Signal transduction pathways control gene expression by modifying the function of nuclear transcription factors. The nuclear accumulation of FOXO1 negatively regulates claudin-5 expression (<xref ref-type="bibr" rid="c7">Beard et al., 2020</xref>; <xref ref-type="bibr" rid="c70">Taddei et al., 2008</xref>). FOXO1 is an important target of the PI3K/AKT signaling axis (<xref ref-type="bibr" rid="c82">Zhang et al., 2011</xref>), and AKT-induced phosphorylation of FOXO1 results in cytoplasmic FOXO1 accumulation and decreases nuclear FOXO1 accumulation (<xref ref-type="bibr" rid="c82">Zhang et al., 2011</xref>). From these results, we inferred that GDNF-induced claudin-5 expression in hCMEC/D3 cells may be involved in the activation of PI3K/AKT/FOXO1 pathway. Similarly, both US-CM and GDNF increased cytoplasmic p-FOXO1 and decreased nuclear FOXO1 in hCMEC/D3 cells, which was reversed by LY29002 rather than U0126. Roles of FOXO1 in GDNF-induced claudin-5 were verified through silencing and overexpressing <italic>FOXO1</italic> in hCMEC/D3 cells. <italic>FOXO1</italic> silencing enhanced claudin-5 but not VE-cadherin expression, accompanied by a decline in total and nuclear FOXO1. In contrast, <italic>FOXO1</italic> overexpression significantly decreased claudin-5 expression. In hCMEC/D3 cells overexpressing <italic>FOXO1</italic>, GDNF lost its promotion effect on claudin-5 expression. It was noticed that U0126 attenuated the GDNF-induced upregulation of claudin-5 but had minimal impact on GDNF-mediated FOXO1 phosphorylation and the decline of nuclear FOXO1. In Sertoli cells, it was found that testosterone stimulated claudin-5 expression by activating the RAS/RAF/ERK/CREB pathway (<xref ref-type="bibr" rid="c13">Bulldan et al., 2016</xref>). The transcriptional regulation of claudin-5 by CREB was confirmed in bEnd.3 (mouse brain endothelial cell). CREB overexpression significantly increased both gene and protein expression of claudin 5. In contrast, depletion of CREB decreased claudin-5 expression in gene and protein levels (Li Y. et al., 2022). However, another report showed that in human lung microvascular endothelial cells, U0126 attenuated phosphorylation of ERK and lipopolysaccharide-stimulated claudin-5 damage, indicating activation of MAPK/ERK pathway impaired rather than promoted claudin-5 expression (Liu Y. et al., 2019). Thus, the real mechanisms that GDNF-induced activation of the RET/MAPK/ERK pathway promotes claudin-5 expression need further investigation.</p>
<p>ETS1 is a member of the ETS family that plays an important role in cell adhesion, migration, and blood vessel information. ETS1 binds to an ETS-binding site located in the proximal region of the VE-cadherin promoter, controlling VE-cadherin expression (<xref ref-type="bibr" rid="c39">Lelièvre et al., 2001</xref>). Several studies have demonstrated the role of ETS1 in the regulation of VE-cadherin expression. For example, IFN-<italic>γ</italic> and TNF-<italic>α</italic> impaired BBB integrity by decreasing ETS1-induced VE-cadherin expression (<xref ref-type="bibr" rid="c49">Luo et al., 2022</xref>). <italic>ETS1</italic> silencing reduced VE-cadherin expression in umbilical vein endothelial cells (<xref ref-type="bibr" rid="c15">Colas-Algora et al., 2020</xref>). In contrast, <italic>ETS1</italic> overexpression induced VE-cadherin expression in mouse brain capillary endothelial cells and fibroblasts (<xref ref-type="bibr" rid="c38">Lelièvre et al., 2000</xref>). As expected, <italic>ETS1</italic> silencing resulted in a decrease in the expression of VE-cadherin in hCMEC/D3 cells, but claudin-5 expression remained unaffected. Additionally, <italic>ETS1</italic> silencing removed the inductive effect of GDNF on VE-cadherin expression while unaffecting the upregulation of claudin-5 induced by GDNF. The activation of the PI3K/AKT (<xref ref-type="bibr" rid="c31">He et al., 2023</xref>; <xref ref-type="bibr" rid="c32">Hui et al., 2018</xref>) and MAPK/ERK (<xref ref-type="bibr" rid="c75">Watanabe et al., 2004</xref>) pathways promotes ETS1 expression. Our findings also demonstrated that US-CM and GDNF significantly increased total and nuclear ETS1 levels, which were eliminated by signaling inhibitors LY294002 and U0126. Both our results and previous research provide evidence that GDNF upregulates ETS1 expression via the activation of PI3K/AKT and MAPK/ERK signaling to promote VE-cadherin expression.</p>
<p>The present study showed that the characteristics of the <italic>in vitro</italic> triple co-culture BBB model were superior to those of the hCMEC/D3 mono-culture BBB model. The hCMEC/D3 mono-culture and triple co-culture BBB models were used to try to predict the <italic>PS</italic> values of 18 drugs by comparing them with their observations. The prediction success rate (14/18) of triple co-culture BBB model was greater than that of hCMEC/D3 mono-culture BBB model (7/18). However, poor predictions were observed for verapamil, amitriptyline, fluoxetine, and clozapine, which may partly be due to inaccuracies in their <italic>f<sub>u, brain</sub></italic> values. These four drugs are high protein-binding drugs. Due to the methodological discordance and the limitations of the historic devices for these drugs, the <italic>f<sub>u</sub></italic> ≤ 0.01 maybe with low confidence and accuracy (Bowman et al., 2018; <xref ref-type="bibr" rid="c19">Di et al., 2017</xref>). For example, <italic>f<sub>u, brain</sub></italic>values of amitriptyline from different reports display large differences (0.002 (<xref ref-type="bibr" rid="c61">Sanchez-Dengra et al., 2021</xref>), 0.0071 (<xref ref-type="bibr" rid="c77">Weber et al., 2013</xref>)). The same large differences of <italic>f<sub>u, brain</sub></italic>values were also found in fluoxetine (0.0023 (<xref ref-type="bibr" rid="c51">Maurer et al., 2005</xref>), 0.004 (<xref ref-type="bibr" rid="c68">Summerfield et al., 2007</xref>), 0.00094 (Liu X. et al., 2005)), and clozapine (0.0056 (<xref ref-type="bibr" rid="c10">Bhyrapuneni et al., 2018</xref>), 0.014 (<xref ref-type="bibr" rid="c16">Cremers et al., 2012</xref>), 0.0094 (<xref ref-type="bibr" rid="c68">Summerfield et al., 2007</xref>)).</p>
<p>In summary, the developed triple co-culture BBB model outperformed the mono-culture or double co-culture BBB models, mainly attributing to the fact that neurons and possibly astrocytes upregulated claudin-5 and VE-cadherin expression by secreting GDNF. GDNF upregulates claudin-5 expression by activating the PI3K/AKT/FOXO1 and MAPK/ERK pathways, and the activation of PI3K/AKT and MAPK/ERK signaling also promotes ETS1 to modify VE-cadherin expression. Additionally, the developed <italic>in vitro</italic> triple co-culture BBB model accurately predicted the <italic>in vivo</italic> BBB permeability of CNS drugs. This suggests the potential of our triple co-culture BBB model for utilization in CNS candidates screening during the drug development process (<xref rid="fig8" ref-type="fig">Figure 8</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>The mechanism of neurons and astrocytes induced the integrity of brain endothelial cells.</title><p>Neurons but also astrocytes trigger the activation of PI3K/AKT and MAPK/ERK pathways in brain endothelial cells by GDNF secretion, which in turn regulates transcription factors of claudin-5 (FOXO1) and VE-cadherin (ETS1) to promote claudin-5 and VE-cadherin expression and leads to the enhancement of BBB integrity. Meanwhile, with the increase in barrier integrity, the <italic>in vitro</italic> BBB model also obtained a stronger <italic>in vivo</italic> correlation.</p></caption>
<graphic xlink:href="579396v1_fig8.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s4">
<title>Materials and Methods</title>
<table-wrap id="utbl1" orientation="portrait" position="float">
<caption><title>Key Resources Table</title></caption>
<graphic xlink:href="579396v1_utbl1.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="579396v1_utbl1a.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="579396v1_utbl1b.tif" mimetype="image" mime-subtype="tiff"/>
<graphic xlink:href="579396v1_utbl1c.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<sec id="s4a">
<title>Cell culture</title>
<p>Rat brain microvascular endothelial cells were isolated from Sprague-Dawley rats (male, 7–10 days old, Sino-British Sippr/BKLaboratory Animal Ltd, Shanghai, China) as the described method (<xref ref-type="bibr" rid="c35">Ji et al., 2013</xref>; Li M. S. et al., 2013) and cultured in Dulbecco’s Modified Eagle Media (DMEM)/F12 (#12500-039, Gibco, Carlsbad, CA, USA) containing 10% fetal bovine serum (FBS) (#10100147C, Gibco, Carlsbad, CA, USA) and 62.5 µg/mL penicillin and 100 µg/mL streptomycin (SunShine Biotechnology Co., ltd. Nanjing, China). Then, hCMEC/D3, U251, and SH-SY5Y cells were cultured in DMEM/F12 containing 10% FBS, 62.5 µg/mL penicillin and 100 µg/mL streptomycin.</p>
</sec>
<sec id="s4b">
<title>Establishment of the triple co-culture model</title>
<p>The establishment process of the triple co-culture model is illustrated in <xref rid="fig1" ref-type="fig">Figure 1A</xref>. SH-SY5Y cells were seeded at a density of 4.5 × 10<sup>4</sup> cells/cm<sup>2</sup> in plates and differentiated with 10 μM retinoic acid (Sigma-Aldrich, St. Louis, MO, USA) for 72 h. The differentiated SH-SY5Y cells were cultured in the fresh DMEM/F12 medium containing 10% FBS. U251 cells were seeded at 2 × 10<sup>4</sup> cells/cm<sup>2</sup> on the bottom of Transwell inserts (0.4 µm pore size, SPL Life Sciences, Pocheon, Korea) coated with rat-tail collagen (Corning Inc., Corning, NY, USA). Next, the inserts were suspended in plate wells containing the culture medium after 5 h of incubation. After 24 h of incubation, hCMEC/D3 cells were seeded on the apical side of the inserts at 3 × 10<sup>4</sup> cells/cm<sup>2</sup> and cultured for another 48 h. Then, the inserts seeded with U251 and hCMEC/D3 cells were suspended in plates seeded with differentiated SH-SY5Y cells and co-cultured for another 6 days. The culture medium was replaced every 24 h.</p>
<p>Three other types of BBB <italic>in vitro</italic> models, namely the hCMEC/D3 cell mono-culture model, the double co-culture with SH-SY5Y cells BBB model, and the double co-culture with U251 cells BBB model were also established (<xref rid="fig1" ref-type="fig">Figure 1B</xref>). TEER was periodically measured using a Millicell-ERS (MERS00002) instrument (Millipore, Billerica MA, USA) to monitor cell confluence and development of tight junctions.</p>
</sec>
<sec id="s4c">
<title><italic>In vitro</italic> BBB permeability study</title>
<p>The culture medium was removed from the apical and basolateral sides of the inserts and washed twice with preheated Hank’s balanced salt solution (HBSS). Fresh HBSS was then added to both the apical and basolateral chambers. After 15 min of preincubation, HBSS in the apical and basolateral chambers was replaced with HBSS containing FITC-dextran 3–5 kDa (FITC-Dex) (Sigma-Aldrich, St. Louis, MO, USA), fluorescein sodium (Sigma-Aldrich, St. Louis, MO, USA), or other tested agents and blank HBSS, respectively. Next, 200 μL aliquots were collected from the basolateral chamber after 30 min of incubation at 37 °C. The concentrations of the tested agents in the basolateral chamber were measured.</p>
<p>The apparent permeability coefficients (<italic>P<sub>app</sub></italic>, cm/s) of the tested agents across the <italic>in vitro</italic> BBB model were calculated using the equation (<xref ref-type="bibr" rid="c72">Tavelin et al., 2002</xref>):
<disp-formula id="eqn1">
<graphic xlink:href="579396v1_eqn1.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
where <italic>S</italic> is the surface area of the insert membrane (0.33 cm<sup>2</sup> for 6.5 mm inserts, 4.46 cm<sup>2</sup> for 24 mm inserts), <italic>Q</italic> is the transported amount of the tested agents transported from the donor chamber to the receiver chamber for 30 min (1800 s), and <italic>C<sub>0</sub></italic> is the initial concentration of the tested agents in the donor chamber.</p>
</sec>
<sec id="s4d">
<title>The quantification methods of prazosin, verapamil, lamotrigine</title>
<p>Prazosin, verapamil, and lamotrigine (Aladdin, Shanghai, China) were analyzed by high-performance liquid chromatography (Shimadzu, Kyoto, Japan) with YMC-Triart C18 column (5 μm, 150 × 4.6 mm, YMC America Inc., Allentown, PA, USA). Prazosin and verapamil were detected using the RF-20A fluorescence detector. Lamotrigine was detected using the SPD-20A ultraviolet detector. Samples were centrifugated at 12000 rpm for 10 mins, then 150 μL supernatant was taken and used for analysis. The run temperature was set at 40 ℃, the injection volume was 20 μL and the flow rate was 1 mL/min. Initial concentrations in donor chamber and other chromatographic conditions of drugs are summarized in <xref rid="tbl1" ref-type="table">Table 1</xref>.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><title>Initial concentrations in donor chamber and chromatographic conditions of prazosin, verapamil, and lamotrigine</title></caption>
<graphic xlink:href="579396v1_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4e">
<title>The quantification methods of clozapine, venlafaxine, bupropion, amantadine, carbamazepine, fluoxetine, amitriptyline, gabapentin, midazolam, risperidone, olanzapine, mirtazapine, metoclopramide, doxepin, donepezil</title>
<p>All compounds were purchased from Aladdin (Shanghai, China). Except for prazosin, verapamil, and lamotrigine, the other compounds were analyzed by using liquid chromatography-mass spectrometry (Shimadzu, Kyoto, Japan) with YMC-Triart C18 column (5 μm, 150 × 2.0 mm, YMC America Inc., Allentown, PA, USA). Each sample was mixed with 10 µL internal standard. Then 1 mL extraction was added to each sample. The samples were vortex vibrated on the oscillator for 10 min, and then centrifuged at 4 ℃ and 12000 rpm for 10 mins. The supernatant solvent was evaporated with nitrogen flow, then redissolved with 100 µL 40 % (v/v) acetonitrile, and centrifuged at 4 ℃ and 15000 rpm for 10 min. The supernatants were injected into LC-MS for analysis. The injection volume of each sample was 5 µL. The mass charge ratio, extraction, and initial concentrations in donor chamber of drugs were summarized in <xref rid="tbl2" ref-type="table">Table 2</xref>.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2</label>
<caption><title>The summary of mass charge ratio, extraction, initial concentrations in donor chamber</title></caption>
<graphic xlink:href="579396v1_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4f">
<title>Cell proliferation analysis</title>
<p>On day 6 after co-culture, hCMEC/D3 cells were fixed with 4% paraformaldehyde for 15 min and washed with phosphate buffered saline (PBS) for three times. Next, the fixed cells were blocked with 5% goat serum for 2 h and washed with PBS for four times. The blocked cells were incubated with DAPI (Invitrogen, Carlsbad, CA, USA) and washed with PBS for four times. Cell numbers were counted using Cytation5 (BioTek, Winooski, VT, USA).</p>
</sec>
<sec id="s4g">
<title>Reverse transcription and Quantitative real-time PCR (qPCR)</title>
<p>Total RNA of cells was extracted using RNAiso Plus reagent (Takara Bio Inc. Otsu, Shiga, Japan) and reverse transcribed using HiScript III RT SuperMix (Vazyme, Shanghai, China) as the described method (<xref ref-type="bibr" rid="c81">Yang et al., 2023</xref>). Paired primers were synthesized by Tsingke Biotech Co., Ltd (Beijing, China), and their sequences were listed in <xref rid="tbl3" ref-type="table">Table 3</xref>. The SYBR Master Mix was purchased from Yeasen (Shanghai, China). Then, qPCR was performed on the Applied Biosystems QuantStudio 3 real-time PCR system (Thermo Fisher Scientific, Waltham, MA, USA). The mRNA levels of related genes were normalized to <italic>ACTB</italic> or <italic>GAPDH</italic> using the comparative cycle threshold method.</p>
<table-wrap id="tbl3" orientation="portrait" position="float">
<label>Table 3</label>
<caption><title>Primer sequences for qPCR for indicted genes</title></caption>
<graphic xlink:href="579396v1_tbl3.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4h">
<title>Western blotting analysis</title>
<p>Whole-cell and tissue lysates, nucleoprotein, and cytoplasmic protein were prepared using RIPA Lysis Buffer (Beyotime, Shanghai, China) as the described method (<xref ref-type="bibr" rid="c79">Wu et al., 2021</xref>). Proteins were separated through sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred onto nitrocellulose or polyvinylidene difluoride membranes. The membranes were blocked with 5% skim milk and incubated with corresponding primary antibodies at 4 ℃ overnight. After being washed with Tris-buffered saline Tween buffer, the membranes were incubated with secondary antibodies (Cell Signaling Technology, MA, USA) at 1:3000 dilution: Anti-mouse IgG, HRP-linked Antibody (#7076), Anti-rabbit IgG, HRP-linked Antibody (#7074). Protein levels were visualized using a highly sensitive ECL western blotting substrate and a gel imaging system (Tanon Science &amp; Technology, Shanghai, China).</p>
</sec>
<sec id="s4i">
<title>Preparation of conditioned medium</title>
<p>Conditioned medium (CM) of U251 cells (U-CM), SH-SY5Y cells (S-CM), or co-culture of U251 and SH-SY5Y cells (US-CM) were prepared. U251 cells were seeded at the top of the insert membrane and suspended on 6-well plates seeded with differentiated SH-SY5Y cells to co-culture U251 cells with SH-SY5Y cells. The medium was collected every 24 h. The CMs were subsequently used for hCMEC/D3 cell culture after filtrating with 0.2 μm filters for 144 h. The levels of glia-derived neurotrophic factor (GDNF), basic fibroblast growth factor (bFGF), insulin-like growth factor-1 (IGF-1), and transforming growth factor-<italic>β</italic> (TGF-<italic>β</italic>) in CMs were measured using corresponding ELISA kits according to the manufacturers’ instructions.</p>
</sec>
<sec id="s4j">
<title>Neutralization of GDNF with Anti-GDNF Antibody</title>
<p>Exogenous and endogenous GDNF in the medium was neutralized with anti-GDNF antibody (#AF-212-NA, R&amp;D system, Minneapolis, MN, USA). 0.25, 0.5, 1.0 μg/mL anti-GDNF antibody was added into the US-CM or medium containing 200 pg/mL GDNF, and then the medium was preincubated at 4 ℃ for 1 h. The hCMEC/D3 cells were incubated with 200 pg/mL GDNF or US-CM containing anti-GDNF antibody or not for 6 days, and then cell lysate was collected for western blot. The medium was replaced every 24 h.</p>
</sec>
<sec id="s4k">
<title>Transfection of hCMEC/D3</title>
<p>Here, hCMEC/D3 cells were plated in the plates or culture dishes at 6 × 10<sup>4</sup> cells/cm<sup>2</sup> and transfected with 10 nM of negative control or human <italic>FOXO1</italic> and <italic>ETS1</italic> small interfering RNA (siRNA) (Tsingke Biotechnology, Beijing, China) for 12 h using Lipofectamine™ 3000 (Invitrogen, Carlsbad, CA, USA) reagent according to the manufacturer’s instructions. Cells were then incubated with a medium containing GDNF for 72 h. The siRNA sequences of human <italic>FOXO1</italic> and <italic>ETS1</italic> were summarized in <xref rid="tbl4" ref-type="table">Table 4</xref>.</p>
<table-wrap id="tbl4" orientation="portrait" position="float">
<label>Table 4</label>
<caption><title>The target sequences for siRNA or shRNA</title></caption>
<graphic xlink:href="579396v1_tbl4.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4l">
<title>FOXO1 Overexpression by plasmids</title>
<p>The plasmids encoding FOXO1 (EX-Z7404-M02) were constructed by GeneCopoeia (Rockville, MD, USA). The hCMEC/D3 cells were plated in plates or dishes at 6 × 10<sup>4</sup> cells/cm<sup>2</sup>. They were subsequently transfected with 1 µg of negative control or plasmids encoding FOXO1 6 h using Lipofectamine™ 3000 reagent according to the manufacturer’s instructions. Transfected cells were then incubated with the medium containing GDNF for 72 h.</p>
</sec>
<sec id="s4m">
<title>Animals</title>
<p>C57BL/6J mice (male, 4–5 weeks old, 16–18 g, 12 mice) were obtained from Sino-British Sippr/BKLaboratory Animal Ltd (Shanghai, China). Mice were maintained in groups under standard conditions with free access to food and water. Animal studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals (National Institutes of Health) and approved by the Animal Ethics Committee of China Pharmaceutical University (Approval Number: 202307003).</p>
</sec>
<sec id="s4n">
<title>Brain-specific <italic>Gdnf</italic> knockdown and evaluation of BBB permeability</title>
<p>Mice were randomly divided into control (shNC) and <italic>Gdnf</italic> silencing (sh<italic>Gdnf</italic>) groups (6 mice each group). The shRNA sequence of mice <italic>Gdnf</italic> was listed in <xref rid="tbl4" ref-type="table">Table 4</xref>. The 2 × 10<sup>9</sup> viral genome each of pAAV-U6-shRNA (NC2)-CMV-EGFP or pAAV-U6-shRNA (<italic>Gdnf</italic>)-CMV-EGFP (OBio Technology, Beijing, China) were injected into the bilateral lateral ventricle area (relative to the bregma: anterior-posterior –0.3 mm; medial-lateral ±1.0 mm; dorsal-ventral –3.0 mm) through intracerebroventricular (<italic>i.c.v</italic>) infusion. Three weeks following <italic>i.c.v</italic> injection, BBB permeability and expression of corresponding targeted proteins were measured in the mice.</p>
<p>A mixture of FITC-Dex (50 mg/kg) and fluorescein sodium (10 mg/kg) was intravenously administered to experimental mice. Thirty minutes after the injection, the mice were euthanized under isoflurane anesthesia, and brain tissue and plasma samples were obtained quickly. The concentrations of FITC-Dex and fluorescein in the plasma and brain were measured as previously described (Li P. et al., 2022; Zhou Y. et al., 2019). No blinding was performed in animal studies.</p>
</sec>
<sec id="s4o">
<title>The prediction of drug permeability across BBB using the developed in vitro BBB model</title>
<p>The <italic>P<sub>app</sub></italic> values of 18 drugs – prazosin, verapamil, lamotrigine, clozapine, venlafaxine, bupropion, amantadine, carbamazepine, fluoxetine, amitriptyline, gabapentin, midazolam, risperidone, olanzapine, mirtazapine, metoclopramide, doxepin, and donepezil – across the hCMEC/D3 cells mono-culture and triple co-culture models were measured. The predicted <italic>in vivo</italic> permeability-surface area product (<italic>PS</italic>, μL/min/g brain) values across BBB were calculated using the following equation:
<disp-formula id="eqn2">
<graphic xlink:href="579396v1_eqn2.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
where VSA is the luminal area of the vascular space of brain, which was set to 150 cm<sup>2</sup>/g (<xref ref-type="bibr" rid="c24">Fenstermacher et al., 1988</xref>), and <italic>f<sub>u, brain</sub></italic> is the unbound fraction of brain.</p>
<p>The published <italic>in vivo</italic> brain permeability values were unified to observed <italic>PS</italic> (<italic>PS <sub>Obs</sub></italic>) by multiplying by VSA equal to 150 cm<sup>2</sup>/g. The <italic>PS <sub>Obs</sub></italic>and <italic>f<sub>u, brain</sub></italic>of these 18 drugs were summarized in <xref rid="tbl5" ref-type="table">Table 5</xref>. If <italic>PS <sub>Pre</sub></italic> values were within 0.5–2.0 folds of observations, the prediction was considered successful.</p>
<table-wrap id="tbl5" orientation="portrait" position="float">
<label>Table 5.</label>
<caption><title>The unbound fraction in brain (<italic>f<sub>u, brain</sub></italic>), the observed <italic>PS <sub>Obs</sub></italic>, and the predicted <italic>PS</italic> (<italic>PS <sub>Pre</sub></italic>), <italic>P<sub>app</sub></italic> across the hCMEC/D3 mono-culture model (<italic>P<sub>app, Mono</sub></italic>) and triple co-culture model (<italic>P<sub>app, Triple</sub></italic>) of the tested drugs. n=4.</title></caption>
<graphic xlink:href="579396v1_tbl5.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s4p">
<title>Statistical analyses</title>
<p>All results are expressed as mean ± S.E.M. Data were analyzed using GraphPad Prism software version 8.0.2 (GraphPad Software, La Jolla, CA, USA). <italic>P</italic> &lt; 0.05 was considered statistically significant. The unpaired Student’s t-test or unpaired t-test with Welch’s correction for two-group comparisons, and one-way ANOVA followed by Fisher’s LSD test or Welch’s ANOVA test was used for multiple group comparisons. The simple linear regression analysis was used to examine the presence of a linear relationship between two variables.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>The authors would like to give special thanks to the support of the China Pharmaceutical University Pharmaceutical Animal Laboratory Center.</p>
</ack>
<sec id="s5">
<title>Funding information</title>
<table-wrap id="utbl2" orientation="portrait" position="float">
<graphic xlink:href="579396v1_utbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p><bold>Lu Yang:</bold> Conceptualization, Methodology, Investigation, Data curation, and Writing–original draft preparation; <bold>Zijin Lin:</bold> Data curation, Formal analysis; <bold>Ruijing Mu</bold>: Visualisation, Software; <bold>Wenhan Wu</bold>: Formal analysis; <bold>Hao Zhi</bold>: Data curation; <bold>Xiaodong Liu</bold>: Supervision, Conceptualization, Project administration, Funding acquisition<bold>; Hanyu Yang</bold>: Supervision, Conceptualization, Funding acquisition<bold>; Li Liu</bold>: Supervision, Conceptualization, Project administration, Funding acquisition, Resources. All authors reviewed and approved the final version of this manuscript.</p>
</sec>
<sec id="s7">
<title>Declaration of interests</title>
<p>The authors declare no competing interests.</p>
</sec>
<sec id="s8">
<title>Data availability</title>
<p>All data are available in the manuscript and supporting files; source data files for western blots have been provided for all figures.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><string-name><surname>Abbott</surname> <given-names>N J</given-names></string-name>. (<year>2013</year>). <article-title>Blood-brain barrier structure and function and the challenges for CNS drug delivery</article-title>. <source>J Inherit Metab Dis</source>, <volume>36</volume>(<issue>3</issue>), <fpage>437</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-013-9608-0</pub-id></mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Arvanitis</surname> <given-names>C D</given-names></string-name>, <string-name><surname>Ferraro</surname> <given-names>G B</given-names></string-name>, <string-name><surname>Jain</surname> <given-names>R K</given-names></string-name>. (<year>2020</year>). <article-title>The blood-brain barrier and blood-tumour barrier in brain tumours and metastases</article-title>. <source>Nat Rev Cancer</source>, <volume>20</volume>(<issue>1</issue>), <fpage>26</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1038/s41568-019-0205-x</pub-id></mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Asada</surname> <given-names>S</given-names></string-name>, <string-name><surname>Daitoku</surname> <given-names>H</given-names></string-name>, <string-name><surname>Matsuzaki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Saito</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sudo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mukai</surname> <given-names>H</given-names></string-name>, <string-name><surname>Iwashita</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kako</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kishi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kasuya</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Fukamizu</surname> <given-names>A</given-names></string-name>. (<year>2007</year>). <article-title>Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1</article-title>. <source>Cell Signal</source>, <volume>19</volume>(<issue>3</issue>), <fpage>519</fpage>–<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2006.08.015</pub-id></mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Avdeef</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>N</given-names></string-name>. (<year>2010</year>). <article-title>A New In Situ Brain Perfusion Flow Correction Method for Lipophilic Drugs Based on the pH-Dependent Crone-Renkin Equation</article-title>. <source>Pharmaceutical Research</source>, <volume>28</volume>(<issue>3</issue>), <fpage>517</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-010-0298-0</pub-id></mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Banks</surname> <given-names>W A</given-names></string-name>. (<year>2016</year>). <article-title>From blood-brain barrier to blood-brain interface: new opportunities for CNS drug delivery</article-title>. <source>Nat Rev Drug Discov</source>, <volume>15</volume>(<issue>4</issue>), <fpage>275</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/nrd.2015.21</pub-id></mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Barberio</surname> <given-names>C</given-names></string-name>, <string-name><surname>Withers</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mishra</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Couraud</surname> <given-names>P-O</given-names></string-name>, <string-name><surname>Romero I</surname> <given-names>A</given-names></string-name>, <string-name><surname>Weksler</surname> <given-names>B</given-names></string-name>, <string-name><surname>Owens</surname> <given-names>R M</given-names></string-name>. (<year>2022</year>). <article-title>A human-derived neurovascular unit in vitro model to study the effects of cellular cross-talk and soluble factors on barrier integrity</article-title>. <source>Frontiers in Cellular Neuroscience</source>, <volume>16</volume>. <pub-id pub-id-type="doi">10.3389/fncel.2022.1065193</pub-id></mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Beard</surname> <given-names>R S</given-names>, <suffix>Jr</suffix></string-name>., <string-name><surname>Hoettels</surname> <given-names>B A</given-names></string-name>, <string-name><surname>Meegan</surname> <given-names>J E</given-names></string-name>, <string-name><surname>Wertz</surname> <given-names>T S</given-names></string-name>, <string-name><surname>Cha</surname> <given-names>B J</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Oxford</surname> <given-names>J T</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>M H</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>S Y</given-names></string-name>. (<year>2020</year>). <article-title>AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction</article-title>. <source>J Cereb Blood Flow Metab</source>, <volume>40</volume>(<issue>2</issue>), <fpage>374</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1177/0271678X18817512</pub-id></mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Bhallamudi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Roos</surname> <given-names>B B</given-names></string-name>, <string-name><surname>Teske</surname> <given-names>J J</given-names></string-name>, <string-name><surname>Wicher</surname> <given-names>S A</given-names></string-name>, <string-name><surname>McConico</surname> <given-names>A C M P</given-names></string-name>, <string-name><surname>Sathish</surname> <given-names>V</given-names></string-name>, <string-name><surname>Prakash</surname> <given-names>Y S</given-names></string-name>. (<year>2021</year>). <article-title>Glial-derived neurotrophic factor in human airway smooth muscle</article-title>. <source>J Cell Physiol</source>, <volume>236</volume>(<issue>12</issue>), <fpage>8184</fpage>–<lpage>8196</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.30489</pub-id></mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Bhattacharya</surname> <given-names>C</given-names></string-name>, <string-name><surname>Masters</surname> <given-names>A R</given-names></string-name>, <string-name><surname>Bach</surname> <given-names>C</given-names></string-name>, <string-name><surname>Stratford</surname> <given-names>R E</given-names>, <suffix>Jr</suffix></string-name>. (<year>2021</year>). <article-title>Population model analysis of chiral inversion and degradation of bupropion enantiomers, and application to enantiomer specific fraction unbound determination in rat plasma and brain</article-title>. <source>J Pharm Biomed Anal</source>, <volume>195</volume>, <fpage>113872</fpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2020.113872</pub-id></mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Bhyrapuneni</surname> <given-names>G</given-names></string-name>, <string-name><surname>Thentu J</surname> <given-names>B</given-names></string-name>, <string-name><surname>Palacharla V</surname> <given-names>R C</given-names></string-name>, <string-name><surname>Muddana</surname> <given-names>N</given-names></string-name>, <string-name><surname>Aleti R</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ajjala D</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nirogi</surname> <given-names>R</given-names></string-name>. (<year>2018</year>). <article-title>A definite measure of occupancy exposures, seeking with non-radiolabeled in vivo 5-HT2A receptor occupancy and in vitro free fractions</article-title>. <source>J Recept Signal Transduct Res</source>, <volume>38</volume>(<issue>4</issue>), <fpage>359</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1080/10799893.2018.1531888</pub-id></mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Biswas</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cottarelli</surname> <given-names>A</given-names></string-name>, <string-name><surname>Agalliu</surname> <given-names>D</given-names></string-name>. (<year>2020</year>). <article-title>Neuronal and glial regulation of CNS angiogenesis and barriergenesis</article-title>. <source>Development</source>, <volume>147</volume>(<fpage>9</fpage>). <pub-id pub-id-type="doi">10.1242/dev.182279</pub-id></mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Bowman</surname> <given-names>C M</given-names></string-name>, <string-name><surname>Benet</surname> <given-names>L Z</given-names></string-name>. (<year>2018</year>). <article-title>An examination of protein binding and protein-facilitated uptake relating to in vitro-in vivo extrapolation</article-title>. <source>Eur J Pharm Sci</source>, <volume>123</volume>, <fpage>502</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejps.2018.08.008</pub-id></mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Bulldan</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dietze</surname> <given-names>R</given-names></string-name>, <string-name><surname>Shihan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Scheiner-Bobis</surname> <given-names>G</given-names></string-name>. (<year>2016</year>). <article-title>Non-classical testosterone signaling mediated through ZIP9 stimulates claudin expression and tight junction formation in Sertoli cells</article-title>. <source>Cellular Signalling</source>, <volume>28</volume>(<issue>8</issue>), <fpage>1075</fpage>–<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2016.04.015</pub-id></mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Clasadonte</surname> <given-names>J</given-names></string-name>, <string-name><surname>Prevot</surname> <given-names>V</given-names></string-name>. (<year>2017</year>). <article-title>The special relationship: glia–neuron interactions in the neuroendocrine hypothalamus</article-title>. <source>Nature Reviews Endocrinology</source>, <volume>14</volume>(<issue>1</issue>), <fpage>25</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2017.124</pub-id></mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Colas-Algora</surname> <given-names>N</given-names></string-name>, <string-name><surname>Garcia-Weber</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cacho-Navas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Barroso</surname> <given-names>S</given-names></string-name>, <string-name><surname>Caballero</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ribas</surname> <given-names>C</given-names></string-name>, <string-name><surname>Correas</surname> <given-names>I</given-names></string-name>, <string-name><surname>Millan</surname> <given-names>J</given-names></string-name>. (<year>2020</year>). <article-title>Compensatory increase of VE-cadherin expression through ETS1 regulates endothelial barrier function in response to TNFalpha</article-title>. <source>Cell Mol Life Sci</source>, <volume>77</volume>(<issue>11</issue>), <fpage>2125</fpage>–<lpage>2140</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-019-03260-9</pub-id></mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Cremers</surname> <given-names>T I</given-names></string-name>, <string-name><surname>Flik</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hofland</surname> <given-names>C</given-names></string-name>, <string-name><surname>Stratford</surname> <given-names>R E</given-names>, <suffix>Jr</suffix></string-name>. (<year>2012</year>). <article-title>Microdialysis evaluation of clozapine and N-desmethylclozapine pharmacokinetics in rat brain</article-title>. <source>Drug Metab Dispos</source>, <volume>40</volume>(<issue>10</issue>), <fpage>1909</fpage>–<lpage>1916</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.112.045682</pub-id></mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Dejana</surname> <given-names>E</given-names></string-name>, <string-name><surname>Orsenigo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Lampugnani</surname> <given-names>M G</given-names></string-name>. (<year>2008</year>). <article-title>The role of adherens junctions and VE-cadherin in the control of vascular permeability</article-title>. <source>J Cell Sci</source>, <volume>121</volume>(<issue>Pt 13</issue>), <fpage>2115</fpage>–<lpage>2122</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.017897</pub-id></mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Di</surname> <given-names>L</given-names></string-name>, <string-name><surname>Umland</surname> <given-names>J P</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>G</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>D O</given-names></string-name>, <string-name><surname>Troutman</surname> <given-names>M D</given-names></string-name>, <string-name><surname>Liston</surname> <given-names>T E.</given-names></string-name> (<year>2011</year>). <article-title>Species independence in brain tissue binding using brain homogenates</article-title>. <source>Drug Metab Dispos</source>, <volume>39</volume>(<issue>7</issue>), <fpage>1270</fpage>–<lpage>1277</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.111.038778</pub-id></mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Di</surname> <given-names>L</given-names></string-name>, <string-name><surname>Breen</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chambers</surname> <given-names>R</given-names></string-name>, <string-name><surname>Eckley</surname> <given-names>S T</given-names></string-name>, <string-name><surname>Fricke</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ghosh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Harradine</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kalvass</surname> <given-names>J C</given-names></string-name>, <string-name><surname>Ho</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>C A</given-names></string-name>, <string-name><surname>Marathe</surname> <given-names>P</given-names></string-name>, <string-name><surname>Perkins</surname> <given-names>E J</given-names></string-name>, <string-name><surname>Qian</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tse</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yan</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zamek-Gliszczynski</surname> <given-names>M J.</given-names></string-name> (<year>2017</year>). <article-title>Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs</article-title>. <source>J Pharm Sci</source>, <volume>106</volume>(<issue>12</issue>), <fpage>3442</fpage>–<lpage>3452</lpage>. <pub-id pub-id-type="doi">10.1016/j.xphs.2017.09.005</pub-id></mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Di Marco</surname> <given-names>A</given-names></string-name>, <string-name><surname>Gonzalez Paz</surname> <given-names>O</given-names></string-name>, <string-name><surname>Fini</surname> <given-names>I</given-names></string-name>, <string-name><surname>Vignone</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cellucci</surname> <given-names>A</given-names></string-name>, <string-name><surname>Battista</surname> <given-names>M R</given-names></string-name>, <string-name><surname>Auciello</surname> <given-names>G</given-names></string-name>, <string-name><surname>Orsatti</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Monteagudo</surname> <given-names>E</given-names></string-name>, <string-name><surname>Khetarpal</surname> <given-names>V</given-names></string-name>, <string-name><surname>Rose</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dominguez</surname> <given-names>C</given-names></string-name>, <string-name><surname>Herbst</surname> <given-names>T</given-names></string-name>, <string-name><surname>Toledo-Sherman</surname> <given-names>L</given-names></string-name>, <string-name><surname>Summa</surname> <given-names>V</given-names></string-name>, <string-name><surname>Munoz-Sanjuan</surname> <given-names>I.</given-names></string-name> (<year>2019</year>). <article-title>Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington’s Disease</article-title>. <source>Mol Pharm</source>, <volume>16</volume>(<issue>5</issue>), <fpage>2069</fpage>–<lpage>2082</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.9b00042</pub-id></mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Dong</surname> <given-names>C</given-names></string-name>, <string-name><surname>Ubogu</surname> <given-names>E E</given-names></string-name>. (<year>2018</year>). <article-title>GDNF enhances human blood-nerve barrier function in vitro via MAPK signaling pathways</article-title>. <source>Tissue Barriers</source>, <volume>6</volume>(<issue>4</issue>), <fpage>1</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1080/21688370.2018.1546537</pub-id></mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Eigenmann</surname> <given-names>D E</given-names></string-name>, <string-name><surname>Xue</surname> <given-names>G</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>K S</given-names></string-name>, <string-name><surname>Moses</surname> <given-names>A V</given-names></string-name>, <string-name><surname>Hamburger</surname> <given-names>M</given-names></string-name>, <string-name><surname>Oufir</surname> <given-names>M</given-names></string-name>. (<year>2013</year>). <article-title>Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood–brain barrier model for drug permeability studies</article-title>. <source>Fluids Barriers CNS</source>, <volume>10</volume>(<issue>1</issue>), <fpage>33</fpage>. <pub-id pub-id-type="doi">10.1186/2045-8118-10-33</pub-id></mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Esaki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ohashi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>R</given-names></string-name>, <string-name><surname>Natsume-Kitatani</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kawashima</surname> <given-names>H</given-names></string-name>, <string-name><surname>Nagao</surname> <given-names>C</given-names></string-name>, <string-name><surname>Mizuguchi</surname> <given-names>K</given-names></string-name>. (<year>2019</year>). <article-title>Computational Model To Predict the Fraction of Unbound Drug in the Brain</article-title>. <source>J Chem Inf Model</source>, <volume>59</volume>(<issue>7</issue>), <fpage>3251</fpage>–<lpage>3261</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00180</pub-id></mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Fenstermacher</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gross</surname> <given-names>P</given-names></string-name>, <string-name><surname>Sposito</surname> <given-names>N</given-names></string-name>, <string-name><surname>Acuff</surname> <given-names>V</given-names></string-name>, <string-name><surname>Pettersen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gruber</surname> <given-names>K</given-names></string-name>. (<year>1988</year>). <article-title>Structural and Functional Variations in Capillary Systems within the Brain</article-title>. <source>Ann N Y Acad Sci</source>, <volume>529</volume>, <fpage>21</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1988.tb51416.x</pub-id></mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Fielder</surname> <given-names>G C</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>T W</given-names></string-name>, <string-name><surname>Razdan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Perry</surname> <given-names>J K</given-names></string-name>, <string-name><surname>Lobie</surname> <given-names>P E</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>D X</given-names></string-name>. (<year>2018</year>). <article-title>The GDNF Family: A Role in Cancer?</article-title> <source>Neoplasia</source>, <volume>20</volume>(<issue>1</issue>), <fpage>99</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.neo.2017.10.010</pub-id></mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Friden</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bergstrom</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wan</surname> <given-names>H</given-names></string-name>, <string-name><surname>Rehngren</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ahlin</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hammarlund-Udenaes</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bredberg</surname> <given-names>U</given-names></string-name>. (<year>2011</year>). <article-title>Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods</article-title>. <source>Drug Metab Dispos</source>, <volume>39</volume>(<issue>3</issue>), <fpage>353</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.110.035998</pub-id></mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Fu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Huo</surname> <given-names>D</given-names></string-name>, <string-name><surname>Zhi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>R</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>B</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Dai</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tan</surname> <given-names>C</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>. (<year>2021</year>). <article-title>Astrocyte-Derived TGFβ1 Facilitates Blood–Brain Barrier Function via Non-Canonical Hedgehog Signaling in Brain Microvascular Endothelial Cells</article-title>. <source>Brain Sciences</source>, <volume>11</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.3390/brainsci11010077</pub-id></mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Hanafy</surname> <given-names>A S</given-names></string-name>, <string-name><surname>Dietrich</surname> <given-names>D</given-names></string-name>, <string-name><surname>Fricker</surname> <given-names>G</given-names></string-name>, <string-name><surname>Lamprecht</surname> <given-names>A</given-names></string-name>. (<year>2021</year>). <article-title>Blood-brain barrier models: Rationale for selection</article-title>. <source>Adv Drug Deliv Rev</source>, <volume>176</volume>, <fpage>113859</fpage>. <pub-id pub-id-type="doi">10.1016/j.addr.2021.113859</pub-id></mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Hashimoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Greene</surname> <given-names>C</given-names></string-name>, <string-name><surname>Munnich</surname> <given-names>A</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>M</given-names></string-name>. (<year>2023</year>). <article-title>The CLDN5 gene at the blood-brain barrier in health and disease</article-title>. <source>Fluids and Barriers of the CNS</source>, <volume>20</volume>(<fpage>1</fpage>). <pub-id pub-id-type="doi">10.1186/s12987-023-00424-5</pub-id></mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>Hatherell</surname> <given-names>K</given-names></string-name>, <string-name><surname>Couraud</surname> <given-names>P O</given-names></string-name>, <string-name><surname>Romero</surname> <given-names>I A</given-names></string-name>, <string-name><surname>Weksler</surname> <given-names>B</given-names></string-name>, <string-name><surname>Pilkington</surname> <given-names>G J</given-names></string-name>. (<year>2011</year>). <article-title>Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models</article-title>. <source>J Neurosci Methods</source>, <volume>199</volume>(<issue>2</issue>), <fpage>223</fpage>–<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2011.05.012</pub-id></mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>He</surname> <given-names>F</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Q F</given-names></string-name>, <string-name><surname>Li</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>C Z</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>W C</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>L P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>H Y</given-names></string-name>. (<year>2023</year>). <article-title>Melatonin Protects Against Hyperoxia-Induced Apoptosis in Alveolar Epithelial type II Cells by Activating the MT2/PI3K/AKT/ETS1 Signaling Pathway</article-title>. <source>Lung</source>, <volume>201</volume>(<issue>2</issue>), <fpage>225</fpage>–<lpage>234</lpage>. <pub-id pub-id-type="doi">10.1007/s00408-023-00610-0</pub-id></mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Hui</surname> <given-names>K</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yue</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>B</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Hsieh</surname> <given-names>J T</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>L S</given-names></string-name>, <string-name><surname>He</surname> <given-names>D</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>K</given-names></string-name>. (<year>2018</year>). <article-title>RASAL2 inhibits tumor angiogenesis via p-AKT/ETS1 signaling in bladder cancer</article-title>. <source>Cell Signal</source>, <volume>48</volume>, <fpage>38</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2018.04.006</pub-id></mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Igarashi</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Utsumi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Chiba</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yamada-Sasamori</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tobioka</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kamimura</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Furuuchi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kokai</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Nakagawa</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mori</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sawada</surname> <given-names>N</given-names></string-name>. (<year>1999</year>). <article-title>Glial cell line-derived neurotrophic factor induces barrier function of endothelial cells forming the blood-brain barrier</article-title>. <source>Biochem Biophys Res Commun</source>, <volume>261</volume>(<issue>1</issue>), <fpage>108</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1999.0992</pub-id></mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Ito</surname> <given-names>R</given-names></string-name>, <string-name><surname>Umehara</surname> <given-names>K</given-names></string-name>, <string-name><surname>Suzuki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kitamura</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nunoya</surname> <given-names>K I</given-names></string-name>, <string-name><surname>Yamaura</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Imawaka</surname> <given-names>H</given-names></string-name>, <string-name><surname>Izumi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wakayama</surname> <given-names>N</given-names></string-name>, <string-name><surname>Komori</surname> <given-names>T</given-names></string-name>, <string-name><surname>Anzai</surname> <given-names>N</given-names></string-name>, <string-name><surname>Akita</surname> <given-names>H</given-names></string-name>, <string-name><surname>Furihata</surname> <given-names>T</given-names></string-name>. (<year>2019</year>). <article-title>A Human Immortalized Cell-Based Blood-Brain Barrier Triculture Model: Development and Characterization as a Promising Tool for Drug-Brain Permeability Studies</article-title>. <source>Mol Pharm</source>, <volume>16</volume>(<issue>11</issue>), <fpage>4461</fpage>–<lpage>4471</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.9b00519</pub-id></mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Ji</surname> <given-names>B S</given-names></string-name>, <string-name><surname>Cen</surname> <given-names>J</given-names></string-name>, <string-name><surname>He</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y Q</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>. (<year>2013</year>). <article-title>Modulation of P-glycoprotein in rat brain microvessel endothelial cells under oxygen glucose deprivation</article-title>. <source>J Pharm Pharmacol</source>, <volume>65</volume>(<issue>10</issue>), <fpage>1508</fpage>–<lpage>1517</lpage>. <pub-id pub-id-type="doi">10.1111/jphp.12122</pub-id></mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Ko J</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yanai</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nishida</surname> <given-names>T</given-names></string-name>. (<year>2009</year>). <article-title>IGF-1 released by corneal epithelial cells induces up-regulation of N-cadherin in corneal fibroblasts</article-title>. <source>J Cell Physiol</source>, <volume>221</volume>(<issue>1</issue>), <fpage>254</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21850</pub-id></mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Kodaira</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kusuhara</surname> <given-names>H</given-names></string-name>, <string-name><surname>Fujita</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ushiki</surname> <given-names>J</given-names></string-name>, <string-name><surname>Fuse</surname> <given-names>E</given-names></string-name>, <string-name><surname>Sugiyama</surname> <given-names>Y</given-names></string-name>. (<year>2011</year>). <article-title>Quantitative evaluation of the impact of active efflux by p-glycoprotein and breast cancer resistance protein at the blood-brain barrier on the predictability of the unbound concentrations of drugs in the brain using cerebrospinal fluid concentration as a surrogate</article-title>. <source>J Pharmacol Exp Ther</source>, <volume>339</volume>(<issue>3</issue>), <fpage>935</fpage>–<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.111.180398</pub-id></mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><string-name><surname>Lelièvre</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mattot</surname> <given-names>V</given-names></string-name>, <string-name><surname>Huber</surname> <given-names>P</given-names></string-name>, <string-name><surname>Vandenbunde</surname> <given-names>B</given-names></string-name>, <string-name><surname>Soncin</surname> <given-names>F</given-names></string-name>. (<year>2000</year>). <article-title>ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin</article-title>. <source>Oncogene</source>, <volume>19</volume>(<issue>20</issue>), <fpage>2438</fpage>–<lpage>2446</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1203563</pub-id></mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Lelièvre</surname> <given-names>E</given-names></string-name>, <string-name><surname>Lionneton</surname> <given-names>F</given-names></string-name>, <string-name><surname>Soncin</surname> <given-names>F</given-names></string-name>, <string-name><surname>Vandenbunder</surname> <given-names>B</given-names></string-name>. (<year>2001</year>). <article-title>The Ets family contains transcriptional activators and repressors involved in angiogenesis</article-title>. <source>Int J Biochem Cell Biol</source>, <volume>33</volume>(<issue>4</issue>), <fpage>391</fpage>–<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1016/s1357-2725(01)00025-5</pub-id></mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>M S</given-names></string-name>, <string-name><surname>Cen</surname> <given-names>J</given-names></string-name>, <string-name><surname>He</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ji</surname> <given-names>B S</given-names></string-name>. (<year>2013</year>). <article-title>CJY, an isoflavone, interacts with ATPase of P-glycoprotein in the rat brain microvessel endothelial cells (RBMECs)</article-title>. <source>J Chemother</source>, <volume>25</volume>(<issue>6</issue>), <fpage>347</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1179/1973947813Y.0000000094</pub-id></mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>P</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Hong</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jiang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>H</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>. (<year>2022</year>). <article-title>Bile Duct Ligation Impairs Function and Expression of Mrp1 at Rat Blood-Retinal Barrier via Bilirubin-Induced P38 MAPK Pathway Activations</article-title>. <source>Int J Mol Sci</source>, <volume>23</volume>(<fpage>14</fpage>). <pub-id pub-id-type="doi">10.3390/ijms23147666</pub-id></mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>W</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chin</surname> <given-names>I</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Dai</surname> <given-names>H</given-names></string-name>. (<year>2018</year>). <article-title>The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological Conditions</article-title>. <source>Current Neuropharmacology</source>, <volume>16</volume>(<issue>9</issue>), <fpage>1375</fpage>–<lpage>1384</lpage>. <pub-id pub-id-type="doi">10.2174/1570159x16666180222164809</pub-id></mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>P</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>B</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Li</surname> <given-names>P</given-names></string-name>. (<year>2022</year>). <article-title>Muscone and (+)-Borneol Cooperatively Strengthen CREB Induction of Claudin 5 in IL-1β-Induced Endothelium Injury</article-title>. <source>Antioxidants</source>, <volume>11</volume>(<fpage>8</fpage>). <pub-id pub-id-type="doi">10.3390/antiox11081455</pub-id></mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname> <given-names>C H</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>C H</given-names></string-name>, <string-name><surname>Hsu</surname> <given-names>S L</given-names></string-name>, <string-name><surname>Liao</surname> <given-names>L Y</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>T A</given-names></string-name>, <string-name><surname>Hsueh</surname> <given-names>C M</given-names></string-name>. (<year>2016</year>). <article-title>Molecular Mechanisms Responsible for Neuron-Derived Conditioned Medium (NCM)-Mediated Protection of Ischemic Brain</article-title>. <source>PLoS One</source>, <volume>11</volume>(<issue>1</issue>), <fpage>e0146692</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0146692</pub-id></mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>P</given-names></string-name>, <string-name><surname>Ji</surname> <given-names>X</given-names></string-name>, <string-name><surname>Qi</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Chi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>L</given-names></string-name>. (<year>2022</year>). <article-title>Sigma-1 receptor activation alleviates blood-brain barrier disruption post cerebral ischemia stroke by stimulating the GDNF-GFRalpha1-RET pathway</article-title>. <source>Exp Neurol</source>, <volume>347</volume>, <fpage>113867</fpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2021.113867</pub-id></mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>B J</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>C</given-names></string-name>, <string-name><surname>Callegari</surname> <given-names>E</given-names></string-name>, <string-name><surname>Becker</surname> <given-names>S L</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X</given-names></string-name>, <string-name><surname>Cianfrogna</surname> <given-names>J</given-names></string-name>, <string-name><surname>Doran</surname> <given-names>A C</given-names></string-name>, <string-name><surname>Doran</surname> <given-names>S D</given-names></string-name>, <string-name><surname>Gibbs</surname> <given-names>J P</given-names></string-name>, <string-name><surname>Hosea</surname> <given-names>N</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>F R</given-names></string-name>, <string-name><surname>Szewc</surname> <given-names>M A</given-names></string-name>, <string-name><surname>Van Deusen</surname> <given-names>J.</given-names></string-name> (<year>2005</year>). <article-title>Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding</article-title>. <source>J Pharmacol Exp Ther</source>, <volume>313</volume>(<issue>3</issue>), <fpage>1254</fpage>–<lpage>1262</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.079319</pub-id></mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Mu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X</given-names></string-name>, <string-name><surname>Liang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>X</given-names></string-name>. (<year>2019</year>). <article-title>Unfractionated Heparin Alleviates Sepsis-Induced Acute Lung Injury by Protecting Tight Junctions</article-title>. <source>Journal of Surgical Research</source>, <volume>238</volume>, <fpage>175</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2019.01.020</pub-id></mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Lonka-Nevalaita</surname> <given-names>L</given-names></string-name>, <string-name><surname>Lume</surname> <given-names>M</given-names></string-name>, <string-name><surname>Leppänen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jokitalo</surname> <given-names>E</given-names></string-name>, <string-name><surname>Peränen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Saarma</surname> <given-names>M</given-names></string-name>. (<year>2010</year>). <article-title>Characterization of the Intracellular Localization, Processing, and Secretion of Two Glial Cell Line-Derived Neurotrophic Factor Splice Isoforms</article-title>. <source>The Journal of Neuroscience</source>, <volume>30</volume>(<issue>34</issue>), <fpage>11403</fpage>–<lpage>11413</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5888-09.2010</pub-id></mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Luo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>H</given-names></string-name>, <string-name><surname>He</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Zhu D</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hu</surname> <given-names>B</given-names></string-name>. (<year>2022</year>). <article-title>Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition</article-title>. <source>Cell Death Dis</source>, <volume>13</volume>(<issue>5</issue>), <fpage>462</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-022-04888-5</pub-id></mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Mathiisen</surname> <given-names>T M</given-names></string-name>, <string-name><surname>Lehre</surname> <given-names>K P</given-names></string-name>, <string-name><surname>Danbolt</surname> <given-names>N C</given-names></string-name>, <string-name><surname>Ottersen</surname> <given-names>O P</given-names></string-name>. (<year>2010</year>). <article-title>The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction</article-title>. <source>Glia</source>, <volume>58</volume>(<issue>9</issue>), <fpage>1094</fpage>–<lpage>1103</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20990</pub-id></mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Maurer</surname> <given-names>T S</given-names></string-name>, <string-name><surname>Debartolo</surname> <given-names>D B</given-names></string-name>, <string-name><surname>Tess</surname> <given-names>D A</given-names></string-name>, <string-name><surname>Scott</surname> <given-names>D O</given-names></string-name>. (<year>2005</year>). <article-title>Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice</article-title>. <source>Drug Metab Dispos</source>, <volume>33</volume>(<issue>1</issue>), <fpage>175</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.104.001222</pub-id></mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Morita</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yamashita</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sasaki</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Uchida</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Nakajima</surname> <given-names>O</given-names></string-name>, <string-name><surname>Nakamura</surname> <given-names>F</given-names></string-name>, <string-name><surname>Yagi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Taniguchi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Usui</surname> <given-names>H</given-names></string-name>, <string-name><surname>Katoh-Semba</surname> <given-names>R</given-names></string-name>, <string-name><surname>Takei</surname> <given-names>K</given-names></string-name>, <string-name><surname>Goshima</surname> <given-names>Y</given-names></string-name>. (<year>2006</year>). <article-title>Regulation of Dendritic Branching and Spine Maturation by Semaphorin3A-Fyn Signaling</article-title>. <source>The Journal of Neuroscience</source>, <volume>26</volume>(<issue>11</issue>), <fpage>2971</fpage>–<lpage>2980</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5453-05.2006</pub-id></mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Muoio</surname> <given-names>V</given-names></string-name>, <string-name><surname>Persson P</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sendeski M</surname> <given-names>M</given-names></string-name>. (<year>2014</year>). <article-title>The neurovascular unit – concept review</article-title>. <source>Acta Physiol</source>, <volume>210</volume>(<issue>4</issue>), <fpage>790</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1111/apha.12250</pub-id></mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Nakagawa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Deli</surname> <given-names>M A</given-names></string-name>, <string-name><surname>Kawaguchi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Shimizudani</surname> <given-names>T</given-names></string-name>, <string-name><surname>Shimono</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kittel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tanaka</surname> <given-names>K</given-names></string-name>, <string-name><surname>Niwa</surname> <given-names>M</given-names></string-name>. (<year>2009</year>). <article-title>A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes</article-title>. <source>Neurochem Int</source>, <volume>54</volume>(<issue>3-4</issue>), <fpage>253</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2008.12.002</pub-id></mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Nitta</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hata</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gotoh</surname> <given-names>S</given-names></string-name>, <string-name><surname>Seo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sasaki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hashimoto</surname> <given-names>N</given-names></string-name>, <string-name><surname>Furuse</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tsukita</surname> <given-names>S</given-names></string-name>. (<year>2003</year>). <article-title>Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice</article-title>. <source>J Cell Biol</source>, <volume>161</volume>(<issue>3</issue>), <fpage>653</fpage>–<lpage>660</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200302070</pub-id></mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Nowrangi</surname> <given-names>D S</given-names></string-name>, <string-name><surname>McBride</surname> <given-names>D</given-names></string-name>, <string-name><surname>Manaenko</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dixon</surname> <given-names>B</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>J H</given-names></string-name>. (<year>2019</year>). <article-title>rhIGF-1 reduces the permeability of the blood-brain barrier following intracerebral hemorrhage in mice</article-title>. <source>Exp Neurol</source>, <volume>312</volume>, <fpage>72</fpage>–<lpage>81</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2018.11.009</pub-id></mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Ohtsuki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yamaguchi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kamoi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Asashima</surname> <given-names>T</given-names></string-name>, <string-name><surname>Terasaki</surname> <given-names>T</given-names></string-name>. (<year>2007</year>). <article-title>Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells</article-title>. <source>J Cell Physiol</source>, <volume>210</volume>(<issue>1</issue>), <fpage>81</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.20823</pub-id></mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Ohtsuki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ikeda</surname> <given-names>C</given-names></string-name>, <string-name><surname>Uchida</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Sakamoto</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Miller</surname> <given-names>F</given-names></string-name>, <string-name><surname>Glacial</surname> <given-names>F</given-names></string-name>, <string-name><surname>Decleves</surname> <given-names>X</given-names></string-name>, <string-name><surname>Scherrmann</surname> <given-names>J M</given-names></string-name>, <string-name><surname>Couraud</surname> <given-names>P O</given-names></string-name>, <string-name><surname>Kubo</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Tachikawa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Terasaki</surname> <given-names>T</given-names></string-name>. (<year>2013</year>). <article-title>Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model</article-title>. <source>Mol Pharm</source>, <volume>10</volume>(<issue>1</issue>), <fpage>289</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1021/mp3004308</pub-id></mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Palmiotti</surname> <given-names>C A</given-names></string-name>, <string-name><surname>Prasad</surname> <given-names>S</given-names></string-name>, <string-name><surname>Naik</surname> <given-names>P</given-names></string-name>, <string-name><surname>Abul</surname> <given-names>K M</given-names></string-name>, <string-name><surname>Sajja</surname> <given-names>R K</given-names></string-name>, <string-name><surname>Achyuta</surname> <given-names>A H</given-names></string-name>, <string-name><surname>Cucullo</surname> <given-names>L</given-names></string-name>. (<year>2014</year>). <article-title>In vitro cerebrovascular modeling in the 21st century: current and prospective technologies</article-title>. <source>Pharm Res</source>, <volume>31</volume>(<issue>12</issue>), <fpage>3229</fpage>–<lpage>3250</lpage>. <pub-id pub-id-type="doi">10.1007/s11095-014-1464-6</pub-id></mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Potjewyd</surname> <given-names>G</given-names></string-name>, <string-name><surname>Moxon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Domingos</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hooper</surname> <given-names>N M</given-names></string-name>. (<year>2018</year>). <article-title>Tissue Engineering 3D Neurovascular Units: A Biomaterials and Bioprinting Perspective</article-title>. <source>Trends Biotechnol</source>, <volume>36</volume>(<issue>4</issue>), <fpage>457</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.tibtech.2018.01.003</pub-id></mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Sanchez-Dengra</surname> <given-names>B</given-names></string-name>, <string-name><surname>Gonzalez-Alvarez</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sousa</surname> <given-names>F</given-names></string-name>, <string-name><surname>Bermejo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Gonzalez-Alvarez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sarmento</surname> <given-names>B</given-names></string-name>. (<year>2021</year>). <article-title>In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells</article-title>. <source>Eur J Pharm Biopharm</source>, <volume>163</volume>, <fpage>120</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2021.04.002</pub-id></mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Sauteur</surname> <given-names>L</given-names></string-name>, <string-name><surname>Affolter</surname> <given-names>M</given-names></string-name>, <string-name><surname>Belting</surname> <given-names>H-G</given-names></string-name>. (<year>2017</year>). <article-title>Distinct and redundant functions of Esam and VE-cadherin during vascular morphogenesis</article-title>. <source>Development</source>. <pub-id pub-id-type="doi">10.1242/dev.140038</pub-id></mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Savettieri</surname> <given-names>G</given-names></string-name>, <string-name><surname>Di Liegro</surname> <given-names>I</given-names></string-name>, <string-name><surname>Catania</surname> <given-names>C</given-names></string-name>, <string-name><surname>Licata</surname> <given-names>L</given-names></string-name>, <string-name><surname>Pitarresi</surname> <given-names>G L</given-names></string-name>, <string-name><surname>D’Agostino</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gabriella</surname> <given-names>S</given-names></string-name>, <string-name><surname>De Caro</surname> <given-names>V</given-names></string-name>, <string-name><surname>Giandalia</surname> <given-names>G</given-names></string-name>, <string-name><surname>Giannola</surname> <given-names>L I</given-names></string-name>, <string-name><surname>Cestelli</surname> <given-names>A.</given-names></string-name> (<year>2000</year>). <article-title>Neurons and ECM regulate occludin localization in brain endothelial cells</article-title>. <source>Neuroreport</source>, <volume>11</volume>(<issue>5</issue>), <fpage>1081</fpage>–<lpage>1084</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-200004070-00035</pub-id></mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Schiera</surname> <given-names>G</given-names></string-name>, <string-name><surname>Bono</surname> <given-names>E</given-names></string-name>, <string-name><surname>Raffa M</surname> <given-names>P</given-names></string-name>, <string-name><surname>Gallo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pitarresi G</surname> <given-names>L</given-names></string-name>, <string-name><surname>Di Liegro</surname> <given-names>I</given-names></string-name>, <string-name><surname>Savettieri</surname> <given-names>G.</given-names></string-name> (<year>2003</year>). <article-title>Synergistic effects of neurons and astrocytes on the differentiation of brain capillary endothelial cells in culture</article-title>. <source>J Cell Mol Med</source>, <volume>7</volume>(<issue>2</issue>), <fpage>165</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2003.tb00215.x</pub-id></mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Schiera</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sala</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gallo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Raffa</surname> <given-names>M P</given-names></string-name>, <string-name><surname>Pitarresi</surname> <given-names>G L</given-names></string-name>, <string-name><surname>Savettieri</surname> <given-names>G</given-names></string-name>, <string-name><surname>Di Liegro</surname> <given-names>I.</given-names></string-name> (<year>2005</year>). <article-title>Permeability properties of a three-cell type in vitro model of blood-brain barrier</article-title>. <source>Journal of Cellular and Molecular Medicine</source>, <volume>9</volume>(<issue>2</issue>), <fpage>373</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1111/j.1582-4934.2005.tb00362.x</pub-id></mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>Shimizu</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sano</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Abe</surname> <given-names>M A</given-names></string-name>, <string-name><surname>Maeda</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ohtsuki</surname> <given-names>S</given-names></string-name>, <string-name><surname>Terasaki</surname> <given-names>T</given-names></string-name>, <string-name><surname>Kanda</surname> <given-names>T</given-names></string-name>. (<year>2011</year>). <article-title>Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors</article-title>. <source>J Cell Physiol</source>, <volume>226</volume>(<issue>1</issue>), <fpage>255</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.22337</pub-id></mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Shimizu</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sano</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Saito</surname> <given-names>K</given-names></string-name>, <string-name><surname>Abe</surname> <given-names>M A</given-names></string-name>, <string-name><surname>Maeda</surname> <given-names>T</given-names></string-name>, <string-name><surname>Haruki</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kanda</surname> <given-names>T</given-names></string-name>. (<year>2012</year>). <article-title>Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier</article-title>. <source>Neurochem Res</source>, <volume>37</volume>(<issue>2</issue>), <fpage>401</fpage>–<lpage>409</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-011-0626-8</pub-id></mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Summerfield</surname> <given-names>S G</given-names></string-name>, <string-name><surname>Read</surname> <given-names>K</given-names></string-name>, <string-name><surname>Begley</surname> <given-names>D J</given-names></string-name>, <string-name><surname>Obradovic</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hidalgo</surname> <given-names>I J</given-names></string-name>, <string-name><surname>Coggon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lewis</surname> <given-names>A V</given-names></string-name>, <string-name><surname>Porter</surname> <given-names>R A</given-names></string-name>, <string-name><surname>Jeffrey</surname> <given-names>P</given-names></string-name>. (<year>2007</year>). <article-title>Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction</article-title>. <source>J Pharmacol Exp Ther</source>, <volume>322</volume>(<issue>1</issue>), <fpage>205</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.107.121525</pub-id></mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Sweeney</surname> <given-names>M D</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Montagne</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>A R</given-names></string-name>, <string-name><surname>Zlokovic</surname> <given-names>B V</given-names></string-name>. (<year>2019</year>). <article-title>Blood-Brain Barrier: From Physiology to Disease and Back</article-title>. <source>Physiol Rev</source>, <volume>99</volume>(<issue>1</issue>), <fpage>21</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00050.2017</pub-id></mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Taddei</surname> <given-names>A</given-names></string-name>, <string-name><surname>Giampietro</surname> <given-names>C</given-names></string-name>, <string-name><surname>Conti</surname> <given-names>A</given-names></string-name>, <string-name><surname>Orsenigo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Breviario</surname> <given-names>F</given-names></string-name>, <string-name><surname>Pirazzoli</surname> <given-names>V</given-names></string-name>, <string-name><surname>Potente</surname> <given-names>M</given-names></string-name>, <string-name><surname>Daly</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dimmeler</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dejana</surname> <given-names>E</given-names></string-name>. (<year>2008</year>). <article-title>Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5</article-title>. <source>Nat Cell Biol</source>, <volume>10</volume>(<issue>8</issue>), <fpage>923</fpage>–<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1752</pub-id></mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Tang</surname> <given-names>E D</given-names></string-name>, <string-name><surname>Nuñez</surname> <given-names>G</given-names></string-name>, <string-name><surname>Barr</surname> <given-names>F G</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>K-L</given-names></string-name>. (<year>1999</year>). <article-title>Negative Regulation of the Forkhead Transcription Factor FKHR by Akt</article-title>. <source>Journal of Biological Chemistry</source>, <volume>274</volume>(<issue>24</issue>), <fpage>16741</fpage>–<lpage>16746</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.274.24.16741</pub-id></mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="book"><string-name><surname>Tavelin</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gråsjö</surname> <given-names>J</given-names></string-name>, <string-name><surname>Taipalensuu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Ocklind</surname> <given-names>G</given-names></string-name>, <string-name><surname>Artursson</surname> <given-names>P</given-names></string-name>. (<year>2002</year>). <chapter-title>Applications of Epithelial Cell Culture in Studies of Drug Transport</chapter-title>. In <person-group person-group-type="editor"><string-name><given-names>C.</given-names> <surname>Wise</surname></string-name></person-group> (Ed.), <source>Epithelial Cell Culture Protocols</source> (pp. <fpage>233</fpage>–<lpage>272</lpage>). <publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Humana Press</publisher-name>. <pub-id pub-id-type="doi">10.1385/1-59259-185-x:233</pub-id></mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Tunggal</surname> <given-names>J A</given-names></string-name>, <string-name><surname>Helfrich</surname> <given-names>I</given-names></string-name>, <string-name><surname>Schmitz</surname> <given-names>A</given-names></string-name>, <string-name><surname>Schwarz</surname> <given-names>H</given-names></string-name>, <string-name><surname>Günzel</surname> <given-names>D</given-names></string-name>, <string-name><surname>Fromm</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kemler</surname> <given-names>R</given-names></string-name>, <string-name><surname>Krieg</surname> <given-names>T</given-names></string-name>, <string-name><surname>Niessen</surname> <given-names>C M</given-names></string-name>. (<year>2005</year>). <article-title>E-cadherin is essential for in vivo epidermal barrier function by regulating tight junctions</article-title>. <source>The EMBO Journal</source>, <volume>24</volume>(<issue>6</issue>), <fpage>1146</fpage>–<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600605</pub-id></mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Wang</surname> <given-names>Z G</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>X C</given-names></string-name>, <string-name><surname>Ye</surname> <given-names>L B</given-names></string-name>, <string-name><surname>Xia</surname> <given-names>Q H</given-names></string-name>, <string-name><surname>Johnson</surname> <given-names>N R</given-names></string-name>, <string-name><surname>Wei</surname> <given-names>X</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>D Q</given-names></string-name>, <string-name><surname>Cao</surname> <given-names>G</given-names></string-name>, <string-name><surname>Fu</surname> <given-names>X B</given-names></string-name>, <string-name><surname>Li</surname> <given-names>X K</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>H Y</given-names></string-name>, <string-name><surname>Xiao</surname> <given-names>J</given-names></string-name>. (<year>2016</year>). <article-title>bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain Injury</article-title>. <source>Mol Neurobiol</source>, <volume>53</volume>(<issue>10</issue>), <fpage>7298</fpage>–<lpage>7311</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9583-6</pub-id></mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Watanabe</surname> <given-names>D</given-names></string-name>, <string-name><surname>Takagi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Suzuma</surname> <given-names>K</given-names></string-name>, <string-name><surname>Suzuma</surname> <given-names>I</given-names></string-name>, <string-name><surname>Oh</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ohashi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kemmochi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Uemura</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ojima</surname> <given-names>T</given-names></string-name>, <string-name><surname>Suganami</surname> <given-names>E</given-names></string-name>, <string-name><surname>Miyamoto</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sato</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Honda</surname> <given-names>Y</given-names></string-name>. (<year>2004</year>). <article-title>Transcription factor Ets-1 mediates ischemia– and vascular endothelial growth factor-dependent retinal neovascularization</article-title>. <source>Am J Pathol</source>, <volume>164</volume>(<issue>5</issue>), <fpage>1827</fpage>–<lpage>1835</lpage>. <pub-id pub-id-type="doi">10.1016/S0002-9440(10)63741-8</pub-id></mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Watanabe</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nakagawa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Morofuji</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Toth A</surname> <given-names>E</given-names></string-name>, <string-name><surname>Vastag</surname> <given-names>M</given-names></string-name>, <string-name><surname>Aruga</surname> <given-names>J</given-names></string-name>, <string-name><surname>Niwa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Deli</surname> <given-names>M A</given-names></string-name>. (<year>2021</year>). <article-title>Characterization of a Primate Blood-Brain Barrier Co-Culture Model Prepared from Primary Brain Endothelial Cells, Pericytes and Astrocytes</article-title>. <source>Pharmaceutics</source>, <volume>13</volume>(<fpage>9</fpage>). <pub-id pub-id-type="doi">10.3390/pharmaceutics13091484</pub-id></mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Weber</surname> <given-names>M L</given-names></string-name>, <string-name><surname>Hofland</surname> <given-names>C M</given-names></string-name>, <string-name><surname>Shaffer</surname> <given-names>C L</given-names></string-name>, <string-name><surname>Flik</surname> <given-names>G</given-names></string-name>, <string-name><surname>Cremers</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hurst</surname> <given-names>R S</given-names></string-name>, <string-name><surname>Rollema</surname> <given-names>H</given-names></string-name>. (<year>2013</year>). <article-title>Therapeutic doses of antidepressants are projected not to inhibit human alpha4beta2 nicotinic acetylcholine receptors</article-title>. <source>Neuropharmacology</source>, <volume>72</volume>, <fpage>88</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.04.027</pub-id></mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Weksler</surname> <given-names>B</given-names></string-name>, <string-name><surname>Romero</surname> <given-names>I A</given-names></string-name>, <string-name><surname>Couraud</surname> <given-names>P-O</given-names></string-name>. (<year>2013</year>). <article-title>The hCMEC/D3 cell line as a model of the human blood brain barrier</article-title>. <source>Fluids and Barriers of the CNS</source>, <volume>10</volume>(<issue>1</issue>), <fpage>16</fpage>. <pub-id pub-id-type="doi">10.1186/2045-8118-10-16</pub-id></mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Wu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Sheng</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Qin</surname> <given-names>Y Y</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>W M</given-names></string-name>, <string-name><surname>Jin</surname> <given-names>M M</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H Y</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>X K</given-names></string-name>, <string-name><surname>Dai</surname> <given-names>C</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X D</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>. (<year>2021</year>). <article-title>Bile duct ligation causes opposite impacts on the expression and function of BCRP and P-gp in rat brain partly via affecting membrane expression of ezrin/radixin/moesin proteins</article-title>. <source>Acta Pharmacol Sin</source>, <volume>42</volume>(<issue>11</issue>), <fpage>1942</fpage>–<lpage>1950</lpage>. <pub-id pub-id-type="doi">10.1038/s41401-020-00602-3</pub-id></mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Xue</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Qi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ma</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>W</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>G</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>X</given-names></string-name>. (<year>2013</year>). <article-title>A Novel Brain Neurovascular Unit Model with Neurons, Astrocytes and Microvascular Endothelial Cells of Rat</article-title>. <source>International Journal of Biological Sciences</source>, <volume>9</volume>(<issue>2</issue>), <fpage>174</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.7150/ijbs.5115</pub-id></mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Su</surname> <given-names>M</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sheng</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mu</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zou</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>. (<year>2023</year>). <article-title>Hepatic retinaldehyde deficiency is involved in diabetes deterioration by enhancing PCK1– and G6PC-mediated gluconeogenesis</article-title>. <source>Acta Pharm Sin B</source>, <volume>13</volume>(<issue>9</issue>), <fpage>3728</fpage>–<lpage>3743</lpage>. <pub-id pub-id-type="doi">10.1016/j.apsb.2023.06.014</pub-id></mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname> <given-names>X</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hadden</surname> <given-names>T J</given-names></string-name>, <string-name><surname>Rishi</surname> <given-names>A K</given-names></string-name>. (<year>2011</year>). <article-title>Akt, FoxO and regulation of apoptosis</article-title>. <source>Biochimica et Biophysica Acta</source>, <volume>1813</volume>(<issue>11</issue>), <fpage>1978</fpage>–<lpage>1986</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2011.03.010</pub-id></mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname> <given-names>L</given-names></string-name>, <string-name><surname>Schmidt</surname> <given-names>K</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>F R</given-names></string-name>, <string-name><surname>Zelesky</surname> <given-names>V</given-names></string-name>, <string-name><surname>Troutman</surname> <given-names>M D</given-names></string-name>, <string-name><surname>Feng</surname> <given-names>B</given-names></string-name>. (<year>2009</year>). <article-title>The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (Gleevec), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-407288) in mice</article-title>. <source>Drug Metab Dispos</source>, <volume>37</volume>(<issue>5</issue>), <fpage>946</fpage>–<lpage>955</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.108.024489</pub-id></mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>J</given-names></string-name>, <string-name><surname>Li</surname> <given-names>P</given-names></string-name>, <string-name><surname>Xie</surname> <given-names>Q</given-names></string-name>, <string-name><surname>Sun</surname> <given-names>B</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>K</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>T</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>L</given-names></string-name>. (<year>2019</year>). <article-title>Increase in P-glycoprotein levels in the blood-brain barrier of partial portal vein ligation /chronic hyperammonemia rats is medicated by ammonia/reactive oxygen species/ERK1/2 activation: In vitro and in vivo studies</article-title>. <source>Eur J Pharmacol</source>, <volume>846</volume>, <fpage>119</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2019.01.005</pub-id></mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96161.1.sa2</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Velasco</surname>
<given-names>Ivan</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Universidad Nacional Autónoma de México</institution>
</institution-wrap>
<city>Mexico City</city>
<country>Mexico</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>The manuscript by Yang and coworkers presents <bold>valuable</bold> evidence that an in vitro brain blood barrier composed of endothelial cells, astrocytes, and neuroblastoma cells of human origin, would resemble better the in vivo condition. The presented results constitute <bold>solid</bold> evidence that GDNF induces the expression of VE-Cadherin and Claudin-5. Further, silencing of GDNF in the brain of mice altered brain blood barrier properties. This provides a new perspective on the interaction between neurons and endothelial cells and this model can be used to screen the permeability of the brain blood barrier to different drugs.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96161.1.sa1</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>In this manuscript, the authors established an in vitro triple co-culture BBB model and demonstrated its advantages compared with the mono or double co-culture BBB model. Further, the authors used their established in vitro BBB model and combined it with other methodologies to investigate the specific mechanism that co-culture with astrocytes but also neurons enhanced the integrity of endothelial cells.</p>
<p>Strengths:</p>
<p>The results persuasively showed the established triple co-culture BBB model well mimicked several important characteristics of BBB compared with the mono-culture BBB model, including better barrier function and in vivo/in vitro correlation. The human-derived immortalized cells used made the model construction process faster and more efficient, and have a better in vivo correlation without species differences. This model is expected to be a useful high-throughput evaluation tool in the development of CNS drugs.</p>
<p>Based on the previous experimental results, detailed studies investigated how co-culture with neurons and astrocytes promoted claudin-5 and VE-cadherin in endothelial cells, and the specific signaling mechanisms were also studied. Interestingly, the authors found that neurons also released GDNF to promote barrier properties of brain endothelial cells, as most current research has focused on the promoting effect of astrocytes-derived GDNF on BBB. Meanwhile, the author also validated the functions of GDNF for BBB integrity in vivo by silencing GDNF in mouse brains. Overall, the experiments and data presented support their claim that, in addition to astrocytes, neurons also have a promoting effect on the barrier function of endothelial cells through GDNF secretion.</p>
<p>Weaknesses:</p>
<p>Although the authors demonstrated a highly usable for predicting the BBB permeability, recorded TEER measurements are still far from the human BBB in vivo reported measurements of TEER, and expression of transporters was not promoted by co-culture, which may lead to the model being unsuitable for studying drug transport mediated by transporters on BBB.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96161.1.sa0</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>Yang and colleagues developed a new in vitro blood-brain barrier model that is relatively simple yet outperforms previous models. By incorporating a neuroblastoma cell line, they demonstrated increased electrical resistance and decreased permeability to small molecules.</p>
<p>Strengths:</p>
<p>The authors initially elucidated the soluble mediator responsible for enhancing endothelial functionality, namely GDNF. Subsequently, they elucidated the mechanisms by which GDNF upregulates the expression of VE-cadherin and Claudin-5. They further validated these findings in vivo, and demonstrated predictive value for molecular permeability as well. The study is meticulously conducted and easily comprehensible. The conclusions are firmly supported by the data, and the objectives are successfully achieved. This research is poised to advance future investigations in BBB permeability, leakage, dysfunction, disease modeling, and drug delivery, particularly in high-throughput experiments. I anticipate an enthusiastic reception from the community interested in this area. While other studies have produced similar results with tri-cultures (PMID: 25630899), this study notably enhances electrical resistance compared to previous attempts.</p>
<p>Weaknesses:</p>
<p>Considerable effort has been directed towards developing in vitro models that more closely resemble their in vivo counterparts, utilizing stem cell-derived NVU cells. Although these examples are currently rudimentary, they offer better BBB mimicry than Yang's study.</p>
<p>Additionally, some instances might benefit from more robust statistical tests; nonetheless, I do not think this would significantly alter the experimental conclusions.</p>
<p>Similar experiments with tri-cultures yielding analogous results have been reported by other authors (PMID: 25630899). TEER values are a bit higher than the aforementioned experiments; however, this study has values at least one order of magnitude lower than physiological levels.</p>
</body>
</sub-article>
</article>